US20070049806A1 - Vascular access port with physiological sensor - Google Patents
Vascular access port with physiological sensor Download PDFInfo
- Publication number
- US20070049806A1 US20070049806A1 US11/527,167 US52716706A US2007049806A1 US 20070049806 A1 US20070049806 A1 US 20070049806A1 US 52716706 A US52716706 A US 52716706A US 2007049806 A1 US2007049806 A1 US 2007049806A1
- Authority
- US
- United States
- Prior art keywords
- patient
- pressure
- pma
- housing
- vap
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 CC*(C)CN(*)CC Chemical compound CC*(C)CN(*)CC 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0026—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the transmission medium
- A61B5/0028—Body tissue as transmission medium, i.e. transmission systems where the medium is the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0208—Subcutaneous access sites for injecting or removing fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
- A61B5/0008—Temperature signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0208—Subcutaneous access sites for injecting or removing fluids
- A61M2039/0229—Subcutaneous access sites for injecting or removing fluids having means for facilitating assembling, e.g. snap-fit housing or modular design
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3507—Communication with implanted devices, e.g. external control
- A61M2205/3523—Communication with implanted devices, e.g. external control using telemetric means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3561—Range local, e.g. within room or hospital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/202—Blood composition characteristics partial carbon oxide pressure, e.g. partial dioxide pressure (P-CO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/30—Blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/50—Temperature
Definitions
- the present invention generally relates to vascular access ports.
- the present invention relates to vascular access ports having associated physiological sensors.
- VAP Implantable vascular access ports
- Such VAPs generally include a housing containing a reservoir and septum, with a catheter extending from the housing.
- the VAP housing is implanted in a subcutaneous pocket at an accessible location such as the arm, and the catheter extends from the housing to a remote vascular location to provide convenient, repeatable access to the patient's venous or arterial system in the body.
- the septum of the VAP may be pierced by a needle that is coupled via appropriate tubing to a therapeutic agent source in an intravenous bag or infusion pump, for example, so that the therapeutic agents may be administered.
- a vascular access system may be used in the home or other outpatient settings, as well as inpatient hospital settings.
- infusing therapeutic agents When infusing therapeutic agents, it is important to monitor certain patient physiological parameters in order to assess if the therapeutic agent is having the desired benefit and/or is causing detrimental side effects.
- home infusions of antibiotics are often prescribed for patients suffering from aggressive bacterial infections. These infusions are administered for weeks and then terminated if no apparent clinical symptoms exist. In some instances, however, patients remain infected even though no symptoms exist.
- the residual infection often manifests itself as random temperature spikes lasting for tens of minutes (known as infection rebound or breakthrough) and the patient may or may not be aware of its existence. As such, patient temperature should be monitored because such temperature spikes should signal the attending physician to change antibiotics.
- infused inotropic or antihypertensive drugs require patient blood pressure monitoring because of possible hypo or hypertension side effects that may be life threatening.
- Blood pressure monitoring typically includes a blood pressure cuff device.
- these devices are not desirable due to lack of continuous monitoring and lack of patient compliance in outpatient settings. For example, because temperature spikes only last a brief period of time as discussed above, periodic monitoring may not catch the temperature spike.
- these monitoring devices require patient use, and because typical patients do not have professional health care training, the devices are susceptible to incorrect usage, potentially resulting in erroneous measurements.
- a vascular access port and physiologic parameter (e.g., temperature, blood pressure, etc.) monitoring device may be inter-connected by a cooperative geometry.
- the inter-connected vascular access port and monitoring device may be implanted at the same time and in the same anatomical location (e.g., subcutaneous pocket).
- the monitoring device may include a telemetry unit that transmits physiological measurement data to a local data collection system (e.g., carried by the patient or located in the patient's home), which may re-transmit the data to a remote data collection system (e.g., located at a physician's office or clinic) via a suitable communication link.
- a local data collection system e.g., carried by the patient or located in the patient's home
- a remote data collection system e.g., located at a physician's office or clinic
- the combined vascular access port and monitoring device may be implanted at the same time and in the same anatomical location, it is very convenient for the physician and procedurally cost effective. Also, because the monitoring device does not require patient involvement for effective use, it is not as susceptible to patient non-compliance as prior art monitoring devices. In addition, because the monitoring device permits continuous feedback, it is possible to detect patient symptoms that may occur infrequently and for short periods of time. Furthermore, because the monitoring device permits multiple measurements over a long period of time, it is possible to improve accuracy of measurements that lack repeatability by averaging multiple measurements over a period of time.
- FIG. 1 is a schematic plan view of a vascular access port and physiological monitoring system in accordance with a generic embodiment of the present invention
- FIG. 2A is a schematic view of a vascular access port and physiological monitoring apparatus connected together by a connector element;
- FIG. 2B is a schematic view of a vascular access port and physiological monitoring apparatus connected together by a cooperative geometry
- FIGS. 3A-3D are schematic illustrations of various connector element designs for use in the vascular access port and physiological monitoring apparatus illustrated in FIG. 2A ;
- FIG. 4 is a schematic illustration of a vascular access port for use in the present invention.
- FIG. 5 is a schematic illustration of a physiological monitoring apparatus for use in the present invention.
- FIG. 6 is a perspective view of a vascular access port and physiological monitoring apparatus in accordance with a specific embodiment of the present invention.
- FIG. 7 is an exploded perspective view of the vascular access port and physiological monitoring apparatus illustrated in FIG. 6 ;
- FIG. 8 is a block diagram of the electronics of a physiological monitoring apparatus and associated transceiver for use with the embodiment illustrated in FIG. 6 ;
- FIG. 9A is a perspective view of a pressure transmission catheter having an antenna for use with the physiological monitoring apparatus illustrated in FIG. 6 ;
- FIG. 9B is an end view of the pressure transmission catheter and antenna illustrated in FIG. 9A ;
- FIG. 10A is an end view of an alternative embodiment of a pressure transmission catheter having an antenna
- FIG. 10B is an end view of another alternative embodiment of a pressure transmission catheter having an antenna
- FIG. 11A is a perspective view of a vascular access port and physiological monitoring apparatus having an alternative connector element
- FIG. 11B is a perspective view of a vascular access port and physiological monitoring apparatus having another alternative connector element
- FIG. 11C is a perspective view of a vascular access port and physiological monitoring apparatus connected together by a cooperative geometry
- FIG. 12 is an exploded perspective view of an alternative embodiment of a vascular access port and physiological monitoring apparatus connected together by a common or integral housing;
- FIG. 13 is an exploded perspective view of another alternative embodiment of a vascular access port and physiological monitoring apparatus connected together by a common or integral housing.
- FIG. 1 a schematic plan view of a generic system including a vascular access port (VAP) 100 and physiological monitoring apparatus (PMA) 200 is shown.
- the system may be used to deliver therapeutic agents via the VAP 100 while monitoring the patient 10 with the PMA 200 .
- the therapeutic regimen e.g., dose, delivery rate, delivery schedule, etc. of therapeutic agent administered via the VAP 100
- the dose or delivery rate may be decreased or even terminated to reduce or eliminate the adverse effect.
- the dose or delivery rate may be increased to establish the desired therapeutic effect.
- the administration of therapeutic agent may be initiated via the VAP 100 .
- the PMA 200 provides feedback as to the condition of the patient 10 as indicated by measuring one or more physiological parameters such as blood pressure (arterial, venous, pulse pressure, etc.), temperature, ECG, blood flow velocity, impedance, blood gas levels, blood gas constituents, etc., or combinations thereof.
- the feedback provided by the PMA 200 may be used to automatically or manually modify the therapeutic regimen (i.e., delivery parameters of the therapeutic agent administered via the VAP 100 ) as described above.
- the PMA 200 may provide measurement data indicative of the patient's condition independent of the therapy administered via the VAP 100 .
- the generic system illustrated in FIG. 1 may include a home (local) data collection system (HDCS) 300 which is operably connected to the PMA 200 via communication link 400 , in addition to a physician (remote) data collection system (PDCS) 500 which is operably connected to the HDCS 300 via communication link 600 .
- Communication link 400 may comprise a direct connection (e.g., hardwired transdermal, ohmic, galvanic or body bus) or an indirect (wireless) connection (e.g., radiofrequency, ultrasonic, or infrared transmission).
- the communication link 400 may be provided via a conductive needle (not shown) inserted into the VAP 100 , wherein the needle is electrically coupled to the HDCS 300 via a wired connection, and electrically coupled to the PMA 200 via a conductive septum, for example.
- communication link 600 may comprise a direct (hardwired) or indirect (wireless) connection, optionally making use of a telecommunication system such as the Internet.
- the HDCS 300 may be carried by the patient or may be located in the patient's home, and receives signal data from the PMA 200 via communication link 400 .
- the HDCS 300 may process and store the signal data, and may optionally provide a visual display of the measured parameter and/or an audible alarm indicative of the measured parameter triggering a threshold value.
- the HDCS may obtain an externally derived parameter (e.g., ambient pressure) and associate the external parameter with the signal data from the PMA 200 .
- the data collected and processed by the HDCS 300 may be transferred to the PDCS 500 via communication link 600 , which may be located at a physician's office or clinic.
- the PDCS 500 may further process and store the signal data, and may also provide a visual display of the measured parameter and/or an audible alarm indicative of the measured parameter triggering a threshold value.
- the patient 10 or the patient's care taker may manually alter the therapeutic regimen as described above.
- the physician or health care provider may contact (via HDCS 300 , for example) and instruct the patient 10 or the patient's care taker to manually alter the therapeutic regimen as described above.
- the HDCS 300 may be operably coupled to the infusion pump and may be programmed to modify the delivery parameters as a function of the physiological parameter measured by the PMA 200 and/or as a function of instructions provided by PDCS 500 . Further aspects of the function and use of HDCS 300 and PDCS 500 may be found in U.S.
- the VAP 100 is shown schematically and may comprise a variety of vascular access port (single or dual port) designs known to those skilled in the art, with certain modification as described in more detail hereinafter.
- the VAP 100 includes a portal housing 102 and an elongate tubular infusion catheter 104 extending therefrom.
- An internal reservoir 110 (visible in FIG. 4 ) is contained within the housing 102 .
- the housing 102 includes two openings, both of which are in fluid communication with and provide access to the internal reservoir 110 .
- a side opening in the housing 102 permits passage of the infusion catheter 104 which is in fluid communication with the internal reservoir 110 .
- the side opening in the housing 102 may contain a catheter connector and/or strain relief 108 (visible in FIGS. 2A, 2B and 4 ).
- a top opening in the housing 102 contains a self-sealing septum 106 through which a hypodermic or infusion needle may be removably inserted into the internal reservoir 110 for the delivery of therapeutic agents.
- An example of a suitable VAP 100 is disclosed in U.S. Pat. No. 5,387,192 to Glantz et al., the entire disclosure of which is incorporated herein by reference.
- the VAP 100 may incorporate a needle detector device as described in U.S. patent application Ser. No. 10/246,324, entitled VASCULAR ACCESS PORT WITH NEEDLE DETECTOR, filed on even date herewith, the entire disclosure of which is hereby incorporated by reference.
- the PMA 200 is shown schematically and may comprise a variety of implantable sensor devices known to those skilled in the art, with certain modification as described in more detail hereinafter.
- implantable devices that measure blood pressure are described in U.S. Pat. No. 4,846,191 to Brockway et al., U.S. Pat. No. 6,033,366 to Brockway et al., U.S. Pat. No. 6,296,615 to Brockway et al., and PCT Publication WO 00/16686 to Brockway et al., the entire disclosures of which are incorporated herein by reference.
- Implantable sensor devices that measure temperature, ECG, blood constituents, etc., may be implemented as well.
- An example of an implantable device with a temperature sensor is described in U.S. Pat. No. 5,535,752 to Halperin et al., the entire disclosure of which is incorporated herein by reference.
- An example of an implantable device with temperature, pH and pressure sensing capabilities is disclosed in U.S. Pat. No. 6,285,897 to Kilcoyne et al., the entire disclosure of which is incorporated herein by reference.
- An example of an implantable device with blood flow velocity measuring capabilities is disclosed in U.S. Pat. No. 5,522,394 to Zurbrugg, the entire disclosure of which is incorporated herein by reference.
- an implantable device with blood constituent e.g., blood glucose, blood gas
- blood constituent e.g., blood glucose, blood gas
- the sensor components (transducer and pressure transmission catheter) of the PMA 200 may be replaced by the sensor components of the implantable sensor devices described in the patents identified above.
- the transducer may be located on the PMA housing 202 , or on a catheter or lead extending therefrom. In other instances, the transducer may be located on the VAP housing 102 or the catheter 104 extending therefrom.
- the present invention is described herein primarily with reference to embodiments utilizing a PMA 200 that measures blood pressure as described in Brockway et al. '191.
- the PMA 200 comprises a blood pressure measuring device including a sensor housing 202 with a pressure transmission catheter (PTC) 204 extending therefrom.
- the PMA 200 also includes a pressure transducer and electronics module 210 , a telemetry unit 220 and a power supply 230 (e.g., battery, external power source with transdermal connection, etc.) contained in housing 202 (visible in FIG. 5 ).
- a power supply 230 e.g., battery, external power source with transdermal connection, etc.
- the housing 202 protects the pressure transducer and the electronics module 210 , the telemetry unit 220 , and the power supply 230 from the harsh environment of the human body.
- the housing 202 may be fabricated of a suitable biocompatible material such as titanium or ceramic and may be hermetically sealed. If metallic, the outer surface of the housing 202 may serve as an electrocardiogram (ECG) sensing electrode.
- ECG electrocardiogram
- the housing may include one or more rings (not shown) and/or a mesh fabric (not shown) disposed thereon for attachment to bodily tissue in the subcutaneous pocket.
- the PTC 204 refers pressure from the pressure measurement site to the pressure transducer and electronics module 210 located inside the sensor housing 202 .
- the PTC 204 may comprise a tubular structure with a liquid-filled lumen extending therethrough to a distal opening or port.
- the proximal end of the PTC 204 is connected to the pressure transducer via a nipple tube, thus establishing a fluid path from the pressure transducer to the distal end of the PTC 204 .
- a barrier such as a viscous or movable plug and/or membrane may be disposed in the distal opening of the PTC 204 to isolate the liquid-filled lumen of the PTC 204 from bodily fluids, without impeding pressure transmission therethrough.
- the PTC 204 of the PMA 200 and the infusion catheter 104 of the VAP 100 may be combined into one dual lumen tube, wherein the PMA 200 measures blood pressure and the VAP 100 delivers therapeutic agent in the same blood vessel.
- the PTC 204 the infusion catheter 104 may be combined into a single lumen tube, wherein a valve is used to alternatively provide fluid communication between the PMA 200 and the single lumen catheter to measure blood pressure, and provide fluid communication between the VAP 100 and the single lumen catheter to deliver therapeutic agent.
- the PMA 200 may be used to measure fluid flow and/or pressure in the VAP 100 during infusion, in addition to measuring a physiological parameter.
- the pressure transducer and electronics module 210 may be the same or similar to those described in U.S. Pat. Nos. 4,846,191, 6,033,366, 6,296,615 or PCT Publication WO 00/16686, all to Brockway et al.
- the electronics module provides excitation to the pressure transducer, amplifies the pressure signal, and may digitally code the pressure information for communication to the telemetry unit 220 .
- the electronics module may also provide for temperature compensation of the pressure transducer and provide a calibrated pressure signal.
- the telemetry unit 220 includes telemetry electronics, which may be the same or similar to those described in U.S. Pat. Nos. 4,846,191, 6,033,366, 6,296,615 or PCT Publication WO 00/16686, all to Brockway et al.
- the telemetry unit 220 receives a physiological parameter (e.g., pressure) signal from the pressure transducer and electronics module 210 , and transmits the data signal to the HDCS 300 via communication link 400 .
- a physiological parameter e.g., pressure
- the telemetry unit 220 may include memory interrogatable by the HDCS 300 .
- Communication link 400 may comprise a direct connection (e.g., hardwired transdermal, ohmic, galvanic or body bus) or an indirect (wireless) connection (e.g., radiofrequency, ultrasonic, or infrared transmission).
- a telemetry coil or antenna may be provided in the housing 202 , or an antenna may be provided in the PTC 204 as described in more detail hereinafter.
- the pressure as measured by the PMA 200 is influenced by external pressure changes (i.e., barometric pressure) and is preferably corrected to avoid inaccuracies and/or possible misinterpretation of pressure data.
- Barometric pressure can change significantly when a weather front moves through the area where the patient resides, when the patient is riding up an elevator in a tall building or traveling in mountainous areas where changes in elevation are frequent and significant.
- the present invention provides a number of different pressure correction schemes as described herein.
- One general approach is to take barometric pressure measurements simultaneously with measurements taken by the PMA 200 , and subtract the barometric reading from the internal pressure measurement.
- the HDCS 300 may take a barometric pressure reading and subtract the barometric pressure measurement from the pressure measurement transmitted by telemetry unit 220 of the PMA 200 .
- a barometric pressure monitor may be located external to the body and measure barometric pressure at times specified by a controller. Measurements obtained by the BPM are representative of the barometric pressure to which the body of the patient is exposed.
- the BPM may be a small device attached to a belt, worn on the neck as a pendant, on the wrist like a watch, or placed in a purse or briefcase.
- the BPM may be incorporated into the HDCS 300 , for example.
- the absolute value of barometric pressure is stored in the memory of a computing device, which may be incorporated into the BPM, for example.
- the absolute value of barometric pressure is stored in the memory along with a time stamp (e.g. year, month, day, hour, minute and second).
- a time stamp e.g. year, month, day, hour, minute and second.
- each subsequent barometric pressure measurement is compared to the stored measurement and evaluated to determine if the difference between that measurement and the stored measurement exceeds a predetermined threshold (e.g. 0.5 mmHg). If the difference is less than the threshold, no further action is taken on that measurement. If the difference is greater than or equal to the threshold, then that value is saved in memory along with a time stamp. If a chronic time series is collected from the patient, the memory of the computing device in the BPM contains barometric pressure values at each point in time where the pressure changed significantly (significant as determined by the preset value).
- pressure measurements taken by the PMA 200 are made with respect to a specific reference pressure, normally to a vacuum. Pressure measurements are recorded into memory in the PMA 200 . Measurements are stored in a way that allows the date and time of the recording to be established. At various times, the pressure measurements recorded in the PMA 200 are transferred to an external combining device (CD) through means of a wireless link.
- CD may also be incorporated into the HDCS 300 , for example, and the BPM also has the ability to transfer measurements to the CD.
- This transfer can be made through a hard link (e.g., electrically conductive wires or fiber optics) if the BPM and CD are in the same unit such as HDCS 300 , or via a wireless link (e.g., RF transmission) if the BPM and CD are remote from each other.
- the CD can correct the measurements obtained from the PMA 200 for barometric pressure. Knowing the barometric pressure measurements at the starting time and at each point thereafter when pressure changes by a significant amount, it is possible to know the barometric pressure at any time up until the date and time of the last value recorded in memory. Correction of a measurement from the PMA 200 for barometric pressure can be achieved by subtracting the barometric pressure measurement reconstructed at that time point, or by mathematically manipulating the two time series to achieve a result equivalent to subtraction.
- a variation of this approach is to record corrected measurements within the PMA 200 .
- it is useful to have the corrected pressure measurements available within the PMA 200 such as when the PMA 200 is in communication with a device that is providing therapeutic effect, such as an infusion pump, pacemaker or defibrillator, and is relying on accurate pressure measurements to adjust the therapy parameters.
- a therapeutic device may be implanted or external (e.g., a drug infusion pump or wearable defibrillator).
- the BPM may transmit barometric pressure data to the PMA 200 , which subtracts the barometric measurement from the in vivo pressure measurement and utilizes or otherwise stores the corrected measurement.
- the in vivo pressure measurements may be transmitted to the BPM which corrects the pressure measurement from the PMA 200 for barometric pressure and transmits the corrected pressure measurement back into the PMA 200 .
- the BPM may evaluate the barometric pressure measurements as they are obtained.
- the BPM would transmit the barometric pressure to the PMA 200 when it is first turned on or brought into the receiving range of the BPM. Once this initial measurement is received by the PMA 200 , if a measurement differs from the previous value by more than a predetermined threshold, then (and only then) would the BPM transmit a barometric pressure measurement to the PMA 200 . The PMA 200 would then send a confirming transmission to the BPM indicating that the transmission of barometric pressure was correctly received. The BPM may continue to send the measurement at regular internals until such confirmation is received.
- a barometric reference pressure may be provided via a needle inserted into a reference septum in the PMA 200 as described with reference to FIGS. 6 and 7 .
- a barometric reference pressure may be provided via a needle inserted into the septum of the VAP 100 , which is in fluid communication with the PMA 200 as described with reference to FIG. 2A .
- the VAP 100 is shown implanted with the housing 102 in a subcutaneous pocket and the catheter 104 inserted in a vein.
- the PMA 200 is shown connected to and adjacent the VAP 100 in the same subcutaneous pocket, with the PTC 204 disposed in an artery.
- the VAP 100 may be implanted in a variety of subcutaneous locations, and that the infusion catheter 104 may be inserted at a variety of venous locations with varying access and terminus sites.
- PMA 200 may be implanted in a variety of subcutaneous locations, and that the PTC 204 may be inserted at a variety of vascular lumens, organ cavities, interstitial spaces etc., depending on the type of sensor utilized and the type of physiological parameter measured. In addition, because some types of sensors do not require a PTC 204 , the PMA 200 may exclude the PTC 204 and simply be implanted adjacent the VAP 100 .
- the infusion catheter 104 of the VAP 100 may be disposed in the basilic vein 24 or cephalic vein 26 which converge into the auxiliary vein 22 .
- the infusion catheter 104 may extend through the auxiliary vein 22 and the superior vena cava 20 , and into the right atrium or right ventricle of the heart 12 .
- the PTC 204 of the PMA 200 may be disposed in the brachial artery 18 which communicates with the left ventricle of the heart 12 via aortic arch 14 and subclavian artery 16 .
- the patient 10 in this example is shown as a human, the present invention is equally applicable to other animals as well.
- the VAP 100 and PMA 200 are connected together by a cooperative connector geometry and a cooperative housing geometry, respectively.
- the cooperative geometry is defined external of the port housing 102 and sensor housing 202 .
- the cooperative geometry is defined internally by one of the VAP 100 and PMA 200 , and externally by the other.
- the term cooperative geometry or geometries refers to geometries that limit relative movement along two or more orthogonal directions or axes. For example, mating geometries and interlocking geometries, whether fixed together or separable, comprises cooperative geometries.
- the connector element 150 includes a port portion 148 and a sensor portion 152 , each of which define geometries that are cooperative.
- the port portion 148 of the connector element 150 may be connected to the port housing 102 , and may be a separate or an integral component.
- the sensor portion 152 of the connector element 150 may be connected to the sensor housing 202 , and may be a separate or an integral component.
- FIGS. 3A-3D Examples of such connector elements 150 with cooperative geometries are shown in FIGS. 3A-3D .
- the connector element 150 A defines a dove-tail interlocking geometry.
- the connector element 150 B defines a ball-and-socket interlocking geometry.
- the connector element 150 C defines a snap-fit (tapered ridge in groove) geometry.
- the connector element 150 D comprises a threaded shaft and bore geometry.
- Connector element 150 may optionally incorporate a lumen 158 through which a fluid path may be established between the VAP 100 and the PMA 200 .
- the lumen 158 may be used, for example, for measuring the pressure or flow rate of fluid infused through VAP 100 utilizing PMA 200 , for providing a reference pressure to the PMA 200 via a secondary port in the VAP 100 , or for utilizing a common catheter for infusion and pressure measurement.
- the port housing 102 and the sensor housing 202 define cooperative geometries.
- the VAP 100 defines an external geometry which cooperates with an internal geometry of the PMA 200 . It is also possible to have the PMA 200 define an external geometry which cooperates with an internal geometry of the VAP 100 .
- the PMA 200 defines a cylindrical hole or recess 206 which accommodates the cylindrical housing 102 of the VAP 100 , in addition to the infusion catheter 104 and the catheter connector/strain relief 108 .
- FIGS. 1-5 and the corresponding text schematically illustrate and describe generic embodiments of the present invention. Reference may be made to FIGS. 6-13 for detailed embodiments that incorporate the general principles discussed above.
- a combined vascular access port and physiological monitoring apparatus is shown generally as 710 .
- the system 710 includes a vascular access port (VAP) 712 and physiological monitoring apparatus (PMA) 714 .
- VAP vascular access port
- PMA physiological monitoring apparatus
- An exploded view of the combined VAP and PMA 710 is shown in FIG. 7 .
- a housing comprising a mating cap 718 and base 720 pair, contains the internal components of both the VAP 712 and PMA 714 .
- the cap 718 is an integrally formed component that includes the side-by-side, generally cylindrical vascular access port portion 722 and the generally triangular-solid shaped PMA portion 724 .
- a plurality of suture holes 726 are provided in the base 720 for securing the housing 718 / 720 to bodily tissue during surgical implantation thereof.
- the VAP 712 includes an infusion catheter 728 that extends from the VAP housing 722 .
- a proximal end 730 of the infusion catheter 728 is connected to and is in fluid communication with a reservoir 754 , and a distal end 732 of the catheter 728 is disposed in the patient's vascular system.
- the therapeutic agent is delivered to the infusion catheter 728 via a needle (not shown), coupled via appropriate tubing to a therapeutic agent source in an intravenous bag or infusion pump, for example, that penetrates the infusion septum 734 and communicates with reservoir 754 .
- the PMA 714 includes a pressure transmission catheter (PTC) 736 coupled at its proximal end 738 to the pressure transducer and electronics package 760 for measuring an internal body pressure.
- PTC pressure transmission catheter
- Such pressure might include, but is not limited to, arterial pressure, venous pressure, cardiac chamber pressure, intracranial pressure, intrauterine pressure, bladder pressure, or intrapleural pressure.
- the PTC 736 may comprise the type described in Brockway '191 or the type described in Brockway '366, for example.
- a pressure reference septum 740 is provided that is penetrable by a needle (not shown) for providing a reference pressure, such as atmospheric pressure.
- a combined VAP and PMA 710 allows the combined convenience of a VAP and the simultaneous ability to monitor a physiological parameter of a patient without requiring a practitioner to independently monitor the parameter. It also allows this to be accomplished in a single surgical procedure which presents virtually no additional surgical effort on behalf of the surgeon who would otherwise have implanted a VAP. It adds virtually no additional procedure time or expense either.
- the cap 718 may be generally about 25 mm in length (l), about 12 mm in width (w), and about 15 mm in height (h).
- the cap 718 may be formed of a titanium, titanium-plastic combination or a titanium-ceramic combination.
- Two access ports (holes) in the cap 718 , infusion septum access port 742 and pressure reference septum access port 744 provide needle access during use to the infusion septum 734 and pressure reference septum 740 , respectively.
- the septa are formed of a silicone elastomeric material. The septa are mechanically secured when the cap 718 is mated to the base 720 .
- the cap 718 mates with the base 720 by pinching an edge 746 of the cap 718 between a wall periphery 748 of the base 720 and a plurality of tabs 750 .
- the distance of the tabs 750 from the wall periphery 748 may be selected relative to the thickness of the edge 746 of the cap 718 to form a snug interference fit.
- the cap 718 and the base 720 may further be adhesively bonded and sealed with a suitable biocompatible adhesive.
- the infusion septum 734 When mated, the infusion septum 734 overlays a top 752 of the fluid reservoir 754 . In this manner, a needle may penetrate the infusion septum 734 and deliver a therapeutic agent to the fluid reservoir 754 . In turn, the therapeutic agent is delivered to the patient via the infusion catheter 728 which is in fluid communication with the fluid reservoir 754 .
- the pressure reference septum 740 is secured between a clamshell structure 756 of the base 720 and a curved portion 758 of the cap. In this manner, it will be appreciated that atmospheric pressure (reference pressure) may be provided via a needle penetrating the pressure reference septum 740 of the PMA 714 , which avoids the use of elaborate barometric pressure reference devices when measuring arterial or venous pressure.
- the PTC 736 is connected to the base 720 via a retaining mechanism 759 .
- the pressure transducer and electronics package 760 powered by battery source 762 , is coupled to the PTC 736 .
- a substrate 764 may support the electronics package 760 and rest on the floor 766 of the base 720 housing.
- the pressure transducer and electronics module 760 of the PMA 714 may be implanted within a patient's body (shown as being to the left side of a dashed line 767 representing the skin surface of the patient) and communicates, regarding measured physiological parameters, with a transceiver 770 external to the patient's body (shown as being to the right side of the dashed line 767 ).
- the pressure transducer and electronics module 760 may comprise a processor 768 having a memory 772 for permanent or temporary storage of various algorithms, routines, computer executable instructions, and/or storage of the measured physiological parameter.
- the memory may be any well known random-access or read-only type memory, or both.
- a temperature input (Temp), a body pressure input (Pressure), an electrocardiogram electrode input (ECG) or other input desired to be measured by the PMA are supplied to the processor 768 via appropriate electronic communications paths.
- Other inputs include, but are not limited to, blood flow, blood glucose, blood gas (e.g., oxygen saturation, CO2).
- the body pressure input may be provided via the PTC 736 and pressure transducer in module 760 as described with reference to FIGS. 6 and 7 .
- the temperature input may be received from a thermistor (not shown) mounted internally or externally to the housing 718 / 720 .
- a benefit of locating the thermistor externally to the housing is to minimize temperature error induced by the therapeutic agent flowing through the VAP and to obtain temperature at a very specific body location.
- the ECG input may be received from a ECG electrodes mounted on the housing 718 / 720 , the PTC 736 , and/or the infusion catheter 728 .
- ECG electrodes 840 may mounted on a bottom surface 841 of base 720 as shown in FIG. 13 .
- the electronics package and battery source may be hermetically sealed to prevent the electronics from electrically shorting or corroding as a result of water vapor penetration.
- the battery source 762 (rechargeable and/or replaceable) provides the power input (Pwr) to the electronics package. It may comprise a physical battery or a capacitor, for example, and may be implanted with the device or located external to the body and wirelessly coupled to the electronics package by utilizing a magnetic coupling, for example.
- a magnetic coupling may utilize an AC powered primary (external) coil disposed on the skin to create an alternating magnetic field which induces power in a secondary (internal) coil connected to the electronics package and disposed under the skin in close proximity to the primary coil.
- Communicating with the processor 768 via communications paths 773 is a transmitter 774 and receiver 776 pair.
- a physiological parameter of the body is measured, it can be communicated, in a delayed (requires writable memory connected processor 768 ) or immediate fashion, in a continuous or discrete manner, as processed or raw data, externally to the body so that a practitioner can use the information in treatment of the patient.
- Preferred transmission methods for the transmitter include, but are not limited to, conduction, radio-frequency waves, magnetic fields, electric fields, sound waves or light waves.
- the processor 768 may process various information from its inputs, and may be coupled to a memory storage device (not shown). For example, it may derive systolic and diastolic pressures, mean pressures, heart rate and/or respiratory rate in the event its input included blood pressure waveforms from the pressure input. Once processed, the transceiver could send requests to the processor indicative of how often the blood pressure is to be sampled and which parameters are to be extracted, for example. As another example, the processor could evaluate its ECG input for rhythm disturbances.
- the transceiver 770 includes a second transmitter 775 and receiver 777 pair. It is powered by an appropriate power source 778 such as an AC or DC source. Via communications paths 780 , the transmitter 775 and receiver 777 communicate with a second processor 782 having a memory 784 . The processor 782 communicates with a visual display 786 so that the practitioner can easily see the value of the measured body physiological parameter. In one embodiment, the display can display more than one physiological parameter at a time. In another, it can cycle between pages of displays. An alarm 788 is provided to aurally and/or visually indicate that one or more of the measured body physiological parameters has exceeded some acceptably defined range of values. In this manner, the patient and/or practitioner can react swiftly in taking corrective action.
- An external connector(s) 790 is provided so that the transceiver can become more robust.
- the external connector can connect by a direct wire or wireless link, such as by radio-frequency or infrared, to a printer, a general or special purpose computer, additional storage devices, faxes, internet, intranets, cell phone, personal data assistant, satellite, or other such computing or peripheral devices.
- the transceiver 770 can embody many forms. For example, in one embodiment it consists of patient strap-on module. In another, it is embodied as a wand to be passed over the patient's skin. In still another, it is coupled physically and electronically together with an infusion pump.
- the transmitter and receiver pair of the electronics package 760 and the transmitter and receiver pair of the transceiver 770 may communicate via the use of an antenna associated with the PTC 736 or infusion catheter 728 .
- an antenna 800 is shown with PTC 736 .
- the catheter may have a length (l), and an inner and outer diameter (di and do).
- the antenna 800 is disposed along a length thereof in a substantially straight manner (as shown), spirally wound manner, or may consist of a plurality of conductors, stranded or braided, to provide flexibility and ruggedness.
- a terminal end 802 of the antenna 800 may be disposed in or adjacent the inner diameter ( FIG. 9B ), adjacent the outer diameter ( FIG.
- the antenna is disposed along only a portion of the length of the catheter and a plurality of antennas, instead of just the one shown, are arranged about the inner and outer diameters of the catheter.
- the transmitter and receiver pairs may include appropriate modulators, demodulators, amplifiers, oscillators, etc., that are well known and necessary for transmitting and receiving signals, in order to accommodate antenna 800 .
- the electronics package only includes a transmitter for communicating externally to the body and does not include a receiver and therefore cannot receive body external information.
- each of the VAP and PMA may, instead of being integrally formed, be combinable with one another before, during or after surgical implantation.
- each of the VAP and the PMA have housings having mating, combinable features.
- the vascular access port housing 722 is slidingly engaged with the PMA housing 724 via mating slot 806 and tab 808 features arranged on an external surface 723 , 725 of the VAP and PMA, respectively.
- the two housings are combinable in an interlocking fit configuration as a ball 810 and socket 812 .
- the male/female parts may be switched and are not limited to the embodiments shown.
- the two housings are combinable as a cap 814 over base 816 configuration. Still other embodiments include, but are not limited to, one-or-more snap-lock features, tongue-groove configurations, or other known or hereinafter invented arrangements. In still other embodiments, the two housings are compatible shapes but are not positively interlocking, such as with a donut shaped PMA surrounding a donut-hole shaped VAP. It should also be appreciated that in any of the foregoing embodiments, more than one PMA may be combined together with a VAP. Also, when made as combinable housings, flexibility is gained because the VAP and PMA can be made and shipped separate from one another and connected in the operating room upon implantation.
- the cap 718 defines the fluid reservoir 754 and the mating cap 718 and base 720 pair contain both the VAP and the physiological monitoring device.
- a bezel 820 secures infusion septum 734 when inner ring 822 is inserted into the fluid reservoir 754 .
- the inner ring is slightly smaller in diameter than the fluid reservoir.
- An inner lip 824 on the outer ring 826 prevents the infusion septum from slipping out of the bezel.
- An outer lip 828 abuts a top 830 of the fluid reservoir 754 when the inner ring is inserted therein.
- An infusion septum access port 742 provides needle access to the infusion septum during use.
- An infusion catheter 728 is fluidly interconnected to the fluid reservoir at a proximal end 730 for communicating a therapeutic agent from the needle (not shown) to a patient via distal end 732 during use.
- An edge 746 of the cap 718 mates about a wall periphery 748 of the base 720 to secure the cap and base together.
- the electronics package 760 Located between the cap and base, preferably as a hermetically sealed module, is the electronics package 760 , battery source 762 , pressure sensor 832 and PTC 736 .
- the electronics package and battery source are hemispherically arranged on a substrate 764 to fit within the outer diameter portion 834 of the cap 718 .
- Suture holes 726 are provided to secure the complete apparatus in a patient during use.
- An antenna may also be included with such structure.
- the mating cap 718 and base 720 sandwich an electronics package 760 , battery source 762 on a substrate 764 .
- a pair of ECG electrodes 840 are mounted on a bottom surface 841 of the base 720 .
- the ECG electrodes monitor an ECG waveform of the patient during use and are implanted in such a manner to achieve this.
- Electronic interconnections (not shown) provide communications between the electrodes and the electronics package.
- the fluid reservoir 754 is defined by the cap 718 and is fluidly interconnected to infusion catheter 728 .
- a PTC 736 is coupled to the cap and to the pressure sensor at proximal end 738 .
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 10/246,348, filed Sep. 17, 2002, the entire disclosure of which is incorporated herein by reference.
- The present invention generally relates to vascular access ports. In particular, the present invention relates to vascular access ports having associated physiological sensors.
- Implantable vascular access ports (VAP) are used extensively in the medical field when recurrent infusions of therapeutic agents into a patient's circulatory system are required over extended periods of time. Such VAPs generally include a housing containing a reservoir and septum, with a catheter extending from the housing. The VAP housing is implanted in a subcutaneous pocket at an accessible location such as the arm, and the catheter extends from the housing to a remote vascular location to provide convenient, repeatable access to the patient's venous or arterial system in the body. In the subcutaneous pocket, the septum of the VAP may be pierced by a needle that is coupled via appropriate tubing to a therapeutic agent source in an intravenous bag or infusion pump, for example, so that the therapeutic agents may be administered. Such a vascular access system may be used in the home or other outpatient settings, as well as inpatient hospital settings.
- When infusing therapeutic agents, it is important to monitor certain patient physiological parameters in order to assess if the therapeutic agent is having the desired benefit and/or is causing detrimental side effects. For example, home infusions of antibiotics are often prescribed for patients suffering from aggressive bacterial infections. These infusions are administered for weeks and then terminated if no apparent clinical symptoms exist. In some instances, however, patients remain infected even though no symptoms exist. The residual infection often manifests itself as random temperature spikes lasting for tens of minutes (known as infection rebound or breakthrough) and the patient may or may not be aware of its existence. As such, patient temperature should be monitored because such temperature spikes should signal the attending physician to change antibiotics. As another example, infused inotropic or antihypertensive drugs require patient blood pressure monitoring because of possible hypo or hypertension side effects that may be life threatening.
- Conventional options for monitoring temperature include oral, rectal, ear or skin type temperature measurement devices. Blood pressure monitoring typically includes a blood pressure cuff device. In addition to inconvenience, these devices are not desirable due to lack of continuous monitoring and lack of patient compliance in outpatient settings. For example, because temperature spikes only last a brief period of time as discussed above, periodic monitoring may not catch the temperature spike. Furthermore, because these monitoring devices require patient use, and because typical patients do not have professional health care training, the devices are susceptible to incorrect usage, potentially resulting in erroneous measurements.
- Thus, there is a need for a monitoring device that is convenient to the patient as well as the physician, provides the potential for continuous monitoring, and reduces patient non-compliance.
- To address this need and others, the present invention provides, in one exemplary embodiment, a vascular access port and physiologic parameter (e.g., temperature, blood pressure, etc.) monitoring device that may be inter-connected by a cooperative geometry. The inter-connected vascular access port and monitoring device may be implanted at the same time and in the same anatomical location (e.g., subcutaneous pocket). The monitoring device may include a telemetry unit that transmits physiological measurement data to a local data collection system (e.g., carried by the patient or located in the patient's home), which may re-transmit the data to a remote data collection system (e.g., located at a physician's office or clinic) via a suitable communication link.
- Because the combined vascular access port and monitoring device may be implanted at the same time and in the same anatomical location, it is very convenient for the physician and procedurally cost effective. Also, because the monitoring device does not require patient involvement for effective use, it is not as susceptible to patient non-compliance as prior art monitoring devices. In addition, because the monitoring device permits continuous feedback, it is possible to detect patient symptoms that may occur infrequently and for short periods of time. Furthermore, because the monitoring device permits multiple measurements over a long period of time, it is possible to improve accuracy of measurements that lack repeatability by averaging multiple measurements over a period of time.
-
FIG. 1 is a schematic plan view of a vascular access port and physiological monitoring system in accordance with a generic embodiment of the present invention; -
FIG. 2A is a schematic view of a vascular access port and physiological monitoring apparatus connected together by a connector element; -
FIG. 2B is a schematic view of a vascular access port and physiological monitoring apparatus connected together by a cooperative geometry; -
FIGS. 3A-3D are schematic illustrations of various connector element designs for use in the vascular access port and physiological monitoring apparatus illustrated inFIG. 2A ; -
FIG. 4 is a schematic illustration of a vascular access port for use in the present invention; -
FIG. 5 is a schematic illustration of a physiological monitoring apparatus for use in the present invention; -
FIG. 6 is a perspective view of a vascular access port and physiological monitoring apparatus in accordance with a specific embodiment of the present invention; -
FIG. 7 is an exploded perspective view of the vascular access port and physiological monitoring apparatus illustrated inFIG. 6 ; -
FIG. 8 is a block diagram of the electronics of a physiological monitoring apparatus and associated transceiver for use with the embodiment illustrated inFIG. 6 ; -
FIG. 9A is a perspective view of a pressure transmission catheter having an antenna for use with the physiological monitoring apparatus illustrated inFIG. 6 ; -
FIG. 9B is an end view of the pressure transmission catheter and antenna illustrated inFIG. 9A ; -
FIG. 10A is an end view of an alternative embodiment of a pressure transmission catheter having an antenna; -
FIG. 10B is an end view of another alternative embodiment of a pressure transmission catheter having an antenna; -
FIG. 11A is a perspective view of a vascular access port and physiological monitoring apparatus having an alternative connector element; -
FIG. 11B is a perspective view of a vascular access port and physiological monitoring apparatus having another alternative connector element; -
FIG. 11C is a perspective view of a vascular access port and physiological monitoring apparatus connected together by a cooperative geometry; -
FIG. 12 is an exploded perspective view of an alternative embodiment of a vascular access port and physiological monitoring apparatus connected together by a common or integral housing; and -
FIG. 13 is an exploded perspective view of another alternative embodiment of a vascular access port and physiological monitoring apparatus connected together by a common or integral housing. - The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
- With reference to
FIG. 1 , a schematic plan view of a generic system including a vascular access port (VAP) 100 and physiological monitoring apparatus (PMA) 200 is shown. The system may be used to deliver therapeutic agents via theVAP 100 while monitoring thepatient 10 with thePMA 200. Based on the patient's condition as measured by thePMA 200, the therapeutic regimen (e.g., dose, delivery rate, delivery schedule, etc. of therapeutic agent administered via the VAP 100) may be changed as needed. For example, if the patient 10 adversely reacts to the therapeutic agent delivered via theVAP 100 as measured by thePMA 200, the dose or delivery rate may be decreased or even terminated to reduce or eliminate the adverse effect. Also by way of example, if thepatient 10 is not responding to the therapeutic agent delivered via theVAP 100 as measured by thePMA 200, the dose or delivery rate may be increased to establish the desired therapeutic effect. Further by way of example, if thepatient 10 demonstrates a need for therapeutic intervention as measured by thePMA 200, the administration of therapeutic agent may be initiated via theVAP 100. - In these and other modes of operation, the
PMA 200 provides feedback as to the condition of the patient 10 as indicated by measuring one or more physiological parameters such as blood pressure (arterial, venous, pulse pressure, etc.), temperature, ECG, blood flow velocity, impedance, blood gas levels, blood gas constituents, etc., or combinations thereof. The feedback provided by thePMA 200 may be used to automatically or manually modify the therapeutic regimen (i.e., delivery parameters of the therapeutic agent administered via the VAP 100) as described above. Alternatively, thePMA 200 may provide measurement data indicative of the patient's condition independent of the therapy administered via theVAP 100. - In addition to the
VAP 100 andPMA 200, the generic system illustrated inFIG. 1 may include a home (local) data collection system (HDCS) 300 which is operably connected to thePMA 200 viacommunication link 400, in addition to a physician (remote) data collection system (PDCS) 500 which is operably connected to theHDCS 300 viacommunication link 600.Communication link 400 may comprise a direct connection (e.g., hardwired transdermal, ohmic, galvanic or body bus) or an indirect (wireless) connection (e.g., radiofrequency, ultrasonic, or infrared transmission). By way of example, not limitation, thecommunication link 400 may be provided via a conductive needle (not shown) inserted into theVAP 100, wherein the needle is electrically coupled to theHDCS 300 via a wired connection, and electrically coupled to thePMA 200 via a conductive septum, for example. Similarly,communication link 600 may comprise a direct (hardwired) or indirect (wireless) connection, optionally making use of a telecommunication system such as the Internet. - The
HDCS 300 may be carried by the patient or may be located in the patient's home, and receives signal data from thePMA 200 viacommunication link 400. TheHDCS 300 may process and store the signal data, and may optionally provide a visual display of the measured parameter and/or an audible alarm indicative of the measured parameter triggering a threshold value. Optionally, the HDCS may obtain an externally derived parameter (e.g., ambient pressure) and associate the external parameter with the signal data from thePMA 200. The data collected and processed by theHDCS 300 may be transferred to thePDCS 500 viacommunication link 600, which may be located at a physician's office or clinic. ThePDCS 500 may further process and store the signal data, and may also provide a visual display of the measured parameter and/or an audible alarm indicative of the measured parameter triggering a threshold value. - Based on information provided by
HDCS 300, the patient 10 or the patient's care taker may manually alter the therapeutic regimen as described above. Similarly, based on information provided byPDCS 500, the physician or health care provider may contact (viaHDCS 300, for example) and instruct the patient 10 or the patient's care taker to manually alter the therapeutic regimen as described above. Alternatively, if the therapeutic agent is delivered to theVAP 100 by an automated infusion pump or the like, theHDCS 300 may be operably coupled to the infusion pump and may be programmed to modify the delivery parameters as a function of the physiological parameter measured by thePMA 200 and/or as a function of instructions provided byPDCS 500. Further aspects of the function and use ofHDCS 300 andPDCS 500 may be found in U.S. patent application Ser. No. 10/077,566, filed Feb. 15, 2002, entitled DEVICES, SYSTEMS AND METHODS FOR ENDOCARDIAL PRESSURE MEASUREMENT, the entire disclosure of which is incorporated herein by reference. - With reference to
FIGS. 1, 2A , 2B, and 4, theVAP 100 is shown schematically and may comprise a variety of vascular access port (single or dual port) designs known to those skilled in the art, with certain modification as described in more detail hereinafter. In the illustrated embodiment, theVAP 100 includes aportal housing 102 and an elongatetubular infusion catheter 104 extending therefrom. An internal reservoir 110 (visible inFIG. 4 ) is contained within thehousing 102. Thehousing 102 includes two openings, both of which are in fluid communication with and provide access to theinternal reservoir 110. A side opening in thehousing 102 permits passage of theinfusion catheter 104 which is in fluid communication with theinternal reservoir 110. The side opening in thehousing 102 may contain a catheter connector and/or strain relief 108 (visible inFIGS. 2A, 2B and 4). A top opening in thehousing 102 contains a self-sealingseptum 106 through which a hypodermic or infusion needle may be removably inserted into theinternal reservoir 110 for the delivery of therapeutic agents. An example of asuitable VAP 100, with some modification, is disclosed in U.S. Pat. No. 5,387,192 to Glantz et al., the entire disclosure of which is incorporated herein by reference. As an option, theVAP 100 may incorporate a needle detector device as described in U.S. patent application Ser. No. 10/246,324, entitled VASCULAR ACCESS PORT WITH NEEDLE DETECTOR, filed on even date herewith, the entire disclosure of which is hereby incorporated by reference. - With reference to
FIGS. 1, 2A , 2B, and 5, thePMA 200 is shown schematically and may comprise a variety of implantable sensor devices known to those skilled in the art, with certain modification as described in more detail hereinafter. Examples of implantable devices that measure blood pressure are described in U.S. Pat. No. 4,846,191 to Brockway et al., U.S. Pat. No. 6,033,366 to Brockway et al., U.S. Pat. No. 6,296,615 to Brockway et al., and PCT Publication WO 00/16686 to Brockway et al., the entire disclosures of which are incorporated herein by reference. Other implantable sensor devices that measure temperature, ECG, blood constituents, etc., may be implemented as well. An example of an implantable device with a temperature sensor is described in U.S. Pat. No. 5,535,752 to Halperin et al., the entire disclosure of which is incorporated herein by reference. An example of an implantable device with temperature, pH and pressure sensing capabilities is disclosed in U.S. Pat. No. 6,285,897 to Kilcoyne et al., the entire disclosure of which is incorporated herein by reference. An example of an implantable device with blood flow velocity measuring capabilities is disclosed in U.S. Pat. No. 5,522,394 to Zurbrugg, the entire disclosure of which is incorporated herein by reference. An example of an implantable device with blood constituent (e.g., blood glucose, blood gas) measuring capabilities is disclosed in U.S. Pat. No. 6,122,536 to Sun et al., the entire disclosure of which is incorporated herein by reference. The sensor components (transducer and pressure transmission catheter) of thePMA 200 may be replaced by the sensor components of the implantable sensor devices described in the patents identified above. In some instances, the transducer may be located on thePMA housing 202, or on a catheter or lead extending therefrom. In other instances, the transducer may be located on theVAP housing 102 or thecatheter 104 extending therefrom. - For purposes of illustration, the present invention is described herein primarily with reference to embodiments utilizing a
PMA 200 that measures blood pressure as described in Brockway et al. '191. To this end, in the embodiment illustrated inFIGS. 1, 2A , 2B, and 5, thePMA 200 comprises a blood pressure measuring device including asensor housing 202 with a pressure transmission catheter (PTC) 204 extending therefrom. ThePMA 200 also includes a pressure transducer andelectronics module 210, atelemetry unit 220 and a power supply 230 (e.g., battery, external power source with transdermal connection, etc.) contained in housing 202 (visible inFIG. 5 ). - The
housing 202 protects the pressure transducer and theelectronics module 210, thetelemetry unit 220, and thepower supply 230 from the harsh environment of the human body. Thehousing 202 may be fabricated of a suitable biocompatible material such as titanium or ceramic and may be hermetically sealed. If metallic, the outer surface of thehousing 202 may serve as an electrocardiogram (ECG) sensing electrode. The housing may include one or more rings (not shown) and/or a mesh fabric (not shown) disposed thereon for attachment to bodily tissue in the subcutaneous pocket. - The
PTC 204 refers pressure from the pressure measurement site to the pressure transducer andelectronics module 210 located inside thesensor housing 202. ThePTC 204 may comprise a tubular structure with a liquid-filled lumen extending therethrough to a distal opening or port. The proximal end of thePTC 204 is connected to the pressure transducer via a nipple tube, thus establishing a fluid path from the pressure transducer to the distal end of thePTC 204. A barrier such as a viscous or movable plug and/or membrane may be disposed in the distal opening of thePTC 204 to isolate the liquid-filled lumen of thePTC 204 from bodily fluids, without impeding pressure transmission therethrough. - As an alternative, the
PTC 204 of thePMA 200 and theinfusion catheter 104 of theVAP 100 may be combined into one dual lumen tube, wherein thePMA 200 measures blood pressure and theVAP 100 delivers therapeutic agent in the same blood vessel. As another alternative, thePTC 204 theinfusion catheter 104 may be combined into a single lumen tube, wherein a valve is used to alternatively provide fluid communication between thePMA 200 and the single lumen catheter to measure blood pressure, and provide fluid communication between theVAP 100 and the single lumen catheter to deliver therapeutic agent. In addition or in the alternative, thePMA 200 may be used to measure fluid flow and/or pressure in theVAP 100 during infusion, in addition to measuring a physiological parameter. - The pressure transducer and
electronics module 210 may be the same or similar to those described in U.S. Pat. Nos. 4,846,191, 6,033,366, 6,296,615 or PCT Publication WO 00/16686, all to Brockway et al. The electronics module provides excitation to the pressure transducer, amplifies the pressure signal, and may digitally code the pressure information for communication to thetelemetry unit 220. The electronics module may also provide for temperature compensation of the pressure transducer and provide a calibrated pressure signal. - The
telemetry unit 220 includes telemetry electronics, which may be the same or similar to those described in U.S. Pat. Nos. 4,846,191, 6,033,366, 6,296,615 or PCT Publication WO 00/16686, all to Brockway et al. Thetelemetry unit 220, receives a physiological parameter (e.g., pressure) signal from the pressure transducer andelectronics module 210, and transmits the data signal to theHDCS 300 viacommunication link 400. In addition or in the alternative, thetelemetry unit 220 may include memory interrogatable by theHDCS 300.Communication link 400 may comprise a direct connection (e.g., hardwired transdermal, ohmic, galvanic or body bus) or an indirect (wireless) connection (e.g., radiofrequency, ultrasonic, or infrared transmission). For wireless RF transmission, a telemetry coil or antenna may be provided in thehousing 202, or an antenna may be provided in thePTC 204 as described in more detail hereinafter. - The pressure as measured by the
PMA 200 is influenced by external pressure changes (i.e., barometric pressure) and is preferably corrected to avoid inaccuracies and/or possible misinterpretation of pressure data. Barometric pressure can change significantly when a weather front moves through the area where the patient resides, when the patient is riding up an elevator in a tall building or traveling in mountainous areas where changes in elevation are frequent and significant. Thus, the present invention provides a number of different pressure correction schemes as described herein. - One general approach is to take barometric pressure measurements simultaneously with measurements taken by the
PMA 200, and subtract the barometric reading from the internal pressure measurement. For example, theHDCS 300 may take a barometric pressure reading and subtract the barometric pressure measurement from the pressure measurement transmitted bytelemetry unit 220 of thePMA 200. - For example, a barometric pressure monitor (BPM) may be located external to the body and measure barometric pressure at times specified by a controller. Measurements obtained by the BPM are representative of the barometric pressure to which the body of the patient is exposed. The BPM may be a small device attached to a belt, worn on the neck as a pendant, on the wrist like a watch, or placed in a purse or briefcase. The BPM may be incorporated into the
HDCS 300, for example. - At some time, e.g. the first measurement obtained after the BPM is powered on, the absolute value of barometric pressure is stored in the memory of a computing device, which may be incorporated into the BPM, for example. The absolute value of barometric pressure is stored in the memory along with a time stamp (e.g. year, month, day, hour, minute and second). From then on, each subsequent barometric pressure measurement is compared to the stored measurement and evaluated to determine if the difference between that measurement and the stored measurement exceeds a predetermined threshold (e.g. 0.5 mmHg). If the difference is less than the threshold, no further action is taken on that measurement. If the difference is greater than or equal to the threshold, then that value is saved in memory along with a time stamp. If a chronic time series is collected from the patient, the memory of the computing device in the BPM contains barometric pressure values at each point in time where the pressure changed significantly (significant as determined by the preset value).
- With this approach, pressure measurements taken by the
PMA 200 are made with respect to a specific reference pressure, normally to a vacuum. Pressure measurements are recorded into memory in thePMA 200. Measurements are stored in a way that allows the date and time of the recording to be established. At various times, the pressure measurements recorded in thePMA 200 are transferred to an external combining device (CD) through means of a wireless link. The CD may also be incorporated into theHDCS 300, for example, and the BPM also has the ability to transfer measurements to the CD. This transfer can be made through a hard link (e.g., electrically conductive wires or fiber optics) if the BPM and CD are in the same unit such asHDCS 300, or via a wireless link (e.g., RF transmission) if the BPM and CD are remote from each other. Once data from both thePMA 200 and the BPM are transferred to the CD, the CD can correct the measurements obtained from thePMA 200 for barometric pressure. Knowing the barometric pressure measurements at the starting time and at each point thereafter when pressure changes by a significant amount, it is possible to know the barometric pressure at any time up until the date and time of the last value recorded in memory. Correction of a measurement from thePMA 200 for barometric pressure can be achieved by subtracting the barometric pressure measurement reconstructed at that time point, or by mathematically manipulating the two time series to achieve a result equivalent to subtraction. - A variation of this approach is to record corrected measurements within the
PMA 200. In some cases it is useful to have the corrected pressure measurements available within thePMA 200, such as when thePMA 200 is in communication with a device that is providing therapeutic effect, such as an infusion pump, pacemaker or defibrillator, and is relying on accurate pressure measurements to adjust the therapy parameters. Such a therapeutic device may be implanted or external (e.g., a drug infusion pump or wearable defibrillator). - The BPM may transmit barometric pressure data to the
PMA 200, which subtracts the barometric measurement from the in vivo pressure measurement and utilizes or otherwise stores the corrected measurement. Alternatively, the in vivo pressure measurements may be transmitted to the BPM which corrects the pressure measurement from thePMA 200 for barometric pressure and transmits the corrected pressure measurement back into thePMA 200. - Alternately, the BPM may evaluate the barometric pressure measurements as they are obtained. In this alternative embodiment, the BPM would transmit the barometric pressure to the
PMA 200 when it is first turned on or brought into the receiving range of the BPM. Once this initial measurement is received by thePMA 200, if a measurement differs from the previous value by more than a predetermined threshold, then (and only then) would the BPM transmit a barometric pressure measurement to thePMA 200. ThePMA 200 would then send a confirming transmission to the BPM indicating that the transmission of barometric pressure was correctly received. The BPM may continue to send the measurement at regular internals until such confirmation is received. - Another general approach is to provide a reference pressure for the
PMA 200. For example, a barometric reference pressure may be provided via a needle inserted into a reference septum in thePMA 200 as described with reference toFIGS. 6 and 7 . Alternatively, a barometric reference pressure may be provided via a needle inserted into the septum of theVAP 100, which is in fluid communication with thePMA 200 as described with reference toFIG. 2A . - With reference back to
FIG. 1 , theVAP 100 is shown implanted with thehousing 102 in a subcutaneous pocket and thecatheter 104 inserted in a vein. Similarly, thePMA 200 is shown connected to and adjacent theVAP 100 in the same subcutaneous pocket, with thePTC 204 disposed in an artery. Those skilled in the art will recognize that theVAP 100 may be implanted in a variety of subcutaneous locations, and that theinfusion catheter 104 may be inserted at a variety of venous locations with varying access and terminus sites. Similarly, those skilled in the art will recognize thatPMA 200 may be implanted in a variety of subcutaneous locations, and that thePTC 204 may be inserted at a variety of vascular lumens, organ cavities, interstitial spaces etc., depending on the type of sensor utilized and the type of physiological parameter measured. In addition, because some types of sensors do not require aPTC 204, thePMA 200 may exclude thePTC 204 and simply be implanted adjacent theVAP 100. - In the specific implant example shown in
FIG. 1 , theinfusion catheter 104 of theVAP 100 may be disposed in thebasilic vein 24 orcephalic vein 26 which converge into theauxiliary vein 22. Theinfusion catheter 104 may extend through theauxiliary vein 22 and thesuperior vena cava 20, and into the right atrium or right ventricle of theheart 12. ThePTC 204 of thePMA 200 may be disposed in thebrachial artery 18 which communicates with the left ventricle of theheart 12 viaaortic arch 14 andsubclavian artery 16. Although the patient 10 in this example is shown as a human, the present invention is equally applicable to other animals as well. - With reference to
FIGS. 2A and 2B , theVAP 100 andPMA 200 are connected together by a cooperative connector geometry and a cooperative housing geometry, respectively. InFIG. 2A , the cooperative geometry is defined external of theport housing 102 andsensor housing 202. InFIG. 2B , the cooperative geometry is defined internally by one of theVAP 100 andPMA 200, and externally by the other. As used herein, the term cooperative geometry or geometries refers to geometries that limit relative movement along two or more orthogonal directions or axes. For example, mating geometries and interlocking geometries, whether fixed together or separable, comprises cooperative geometries. - With specific reference to
FIG. 2A , theconnector element 150 includes aport portion 148 and asensor portion 152, each of which define geometries that are cooperative. Theport portion 148 of theconnector element 150 may be connected to theport housing 102, and may be a separate or an integral component. Similarly, thesensor portion 152 of theconnector element 150 may be connected to thesensor housing 202, and may be a separate or an integral component. - Examples of
such connector elements 150 with cooperative geometries are shown inFIGS. 3A-3D . InFIG. 3A , theconnector element 150A defines a dove-tail interlocking geometry. InFIG. 3B , theconnector element 150B defines a ball-and-socket interlocking geometry. InFIG. 3C , theconnector element 150C defines a snap-fit (tapered ridge in groove) geometry. InFIG. 3D , theconnector element 150D comprises a threaded shaft and bore geometry. -
Connector element 150 may optionally incorporate alumen 158 through which a fluid path may be established between theVAP 100 and thePMA 200. Thelumen 158 may be used, for example, for measuring the pressure or flow rate of fluid infused throughVAP 100 utilizingPMA 200, for providing a reference pressure to thePMA 200 via a secondary port in theVAP 100, or for utilizing a common catheter for infusion and pressure measurement. - With specific reference to
FIG. 2B , theport housing 102 and thesensor housing 202 define cooperative geometries. As shown, theVAP 100 defines an external geometry which cooperates with an internal geometry of thePMA 200. It is also possible to have thePMA 200 define an external geometry which cooperates with an internal geometry of theVAP 100. In the illustrated embodiment, thePMA 200 defines a cylindrical hole orrecess 206 which accommodates thecylindrical housing 102 of theVAP 100, in addition to theinfusion catheter 104 and the catheter connector/strain relief 108. -
FIGS. 1-5 and the corresponding text schematically illustrate and describe generic embodiments of the present invention. Reference may be made toFIGS. 6-13 for detailed embodiments that incorporate the general principles discussed above. - With specific reference to
FIG. 6 , a combined vascular access port and physiological monitoring apparatus is shown generally as 710. Thesystem 710 includes a vascular access port (VAP) 712 and physiological monitoring apparatus (PMA) 714. An exploded view of the combined VAP andPMA 710 is shown inFIG. 7 . - A housing, comprising a
mating cap 718 andbase 720 pair, contains the internal components of both theVAP 712 andPMA 714. In this embodiment, thecap 718 is an integrally formed component that includes the side-by-side, generally cylindrical vascularaccess port portion 722 and the generally triangular-solid shapedPMA portion 724. A plurality ofsuture holes 726 are provided in thebase 720 for securing thehousing 718/720 to bodily tissue during surgical implantation thereof. - The
VAP 712 includes aninfusion catheter 728 that extends from theVAP housing 722. Aproximal end 730 of theinfusion catheter 728 is connected to and is in fluid communication with areservoir 754, and adistal end 732 of thecatheter 728 is disposed in the patient's vascular system. The therapeutic agent is delivered to theinfusion catheter 728 via a needle (not shown), coupled via appropriate tubing to a therapeutic agent source in an intravenous bag or infusion pump, for example, that penetrates theinfusion septum 734 and communicates withreservoir 754. - The
PMA 714 includes a pressure transmission catheter (PTC) 736 coupled at itsproximal end 738 to the pressure transducer andelectronics package 760 for measuring an internal body pressure. Such pressure might include, but is not limited to, arterial pressure, venous pressure, cardiac chamber pressure, intracranial pressure, intrauterine pressure, bladder pressure, or intrapleural pressure. ThePTC 736 may comprise the type described in Brockway '191 or the type described in Brockway '366, for example. Apressure reference septum 740 is provided that is penetrable by a needle (not shown) for providing a reference pressure, such as atmospheric pressure. - In this manner, a combined VAP and
PMA 710 is disclosed that allows the combined convenience of a VAP and the simultaneous ability to monitor a physiological parameter of a patient without requiring a practitioner to independently monitor the parameter. It also allows this to be accomplished in a single surgical procedure which presents virtually no additional surgical effort on behalf of the surgeon who would otherwise have implanted a VAP. It adds virtually no additional procedure time or expense either. - Although various geometries are possible, the
cap 718 may be generally about 25 mm in length (l), about 12 mm in width (w), and about 15 mm in height (h). Thecap 718 may be formed of a titanium, titanium-plastic combination or a titanium-ceramic combination. Two access ports (holes) in thecap 718, infusionseptum access port 742 and pressure referenceseptum access port 744, provide needle access during use to theinfusion septum 734 andpressure reference septum 740, respectively. In one embodiment, the septa are formed of a silicone elastomeric material. The septa are mechanically secured when thecap 718 is mated to thebase 720. - In the embodiment shown, the
cap 718 mates with the base 720 by pinching anedge 746 of thecap 718 between awall periphery 748 of thebase 720 and a plurality oftabs 750. The distance of thetabs 750 from thewall periphery 748 may be selected relative to the thickness of theedge 746 of thecap 718 to form a snug interference fit. Thecap 718 and the base 720 may further be adhesively bonded and sealed with a suitable biocompatible adhesive. - When mated, the
infusion septum 734 overlays a top 752 of thefluid reservoir 754. In this manner, a needle may penetrate theinfusion septum 734 and deliver a therapeutic agent to thefluid reservoir 754. In turn, the therapeutic agent is delivered to the patient via theinfusion catheter 728 which is in fluid communication with thefluid reservoir 754. - The
pressure reference septum 740 is secured between aclamshell structure 756 of thebase 720 and acurved portion 758 of the cap. In this manner, it will be appreciated that atmospheric pressure (reference pressure) may be provided via a needle penetrating thepressure reference septum 740 of thePMA 714, which avoids the use of elaborate barometric pressure reference devices when measuring arterial or venous pressure. - The
PTC 736 is connected to thebase 720 via aretaining mechanism 759. The pressure transducer andelectronics package 760, powered bybattery source 762, is coupled to thePTC 736. Asubstrate 764 may support theelectronics package 760 and rest on thefloor 766 of the base 720 housing. - With reference to
FIG. 8 , the pressure transducer andelectronics module 760 of thePMA 714 may be implanted within a patient's body (shown as being to the left side of a dashedline 767 representing the skin surface of the patient) and communicates, regarding measured physiological parameters, with atransceiver 770 external to the patient's body (shown as being to the right side of the dashed line 767). - The pressure transducer and
electronics module 760 may comprise aprocessor 768 having amemory 772 for permanent or temporary storage of various algorithms, routines, computer executable instructions, and/or storage of the measured physiological parameter. The memory may be any well known random-access or read-only type memory, or both. A temperature input (Temp), a body pressure input (Pressure), an electrocardiogram electrode input (ECG) or other input desired to be measured by the PMA are supplied to theprocessor 768 via appropriate electronic communications paths. Other inputs include, but are not limited to, blood flow, blood glucose, blood gas (e.g., oxygen saturation, CO2). - The body pressure input may be provided via the
PTC 736 and pressure transducer inmodule 760 as described with reference toFIGS. 6 and 7 . The temperature input may be received from a thermistor (not shown) mounted internally or externally to thehousing 718/720. A benefit of locating the thermistor externally to the housing is to minimize temperature error induced by the therapeutic agent flowing through the VAP and to obtain temperature at a very specific body location. The ECG input may be received from a ECG electrodes mounted on thehousing 718/720, thePTC 736, and/or theinfusion catheter 728. For example,ECG electrodes 840 may mounted on abottom surface 841 ofbase 720 as shown inFIG. 13 . - The electronics package and battery source may be hermetically sealed to prevent the electronics from electrically shorting or corroding as a result of water vapor penetration. The battery source 762 (rechargeable and/or replaceable) provides the power input (Pwr) to the electronics package. It may comprise a physical battery or a capacitor, for example, and may be implanted with the device or located external to the body and wirelessly coupled to the electronics package by utilizing a magnetic coupling, for example. Such a magnetic coupling may utilize an AC powered primary (external) coil disposed on the skin to create an alternating magnetic field which induces power in a secondary (internal) coil connected to the electronics package and disposed under the skin in close proximity to the primary coil.
- Communicating with the
processor 768 viacommunications paths 773 is atransmitter 774 andreceiver 776 pair. In this manner, once a physiological parameter of the body is measured, it can be communicated, in a delayed (requires writable memory connected processor 768) or immediate fashion, in a continuous or discrete manner, as processed or raw data, externally to the body so that a practitioner can use the information in treatment of the patient. Preferred transmission methods for the transmitter include, but are not limited to, conduction, radio-frequency waves, magnetic fields, electric fields, sound waves or light waves. - The
processor 768 may process various information from its inputs, and may be coupled to a memory storage device (not shown). For example, it may derive systolic and diastolic pressures, mean pressures, heart rate and/or respiratory rate in the event its input included blood pressure waveforms from the pressure input. Once processed, the transceiver could send requests to the processor indicative of how often the blood pressure is to be sampled and which parameters are to be extracted, for example. As another example, the processor could evaluate its ECG input for rhythm disturbances. - In a preferred embodiment, the
transceiver 770 includes asecond transmitter 775 andreceiver 777 pair. It is powered by anappropriate power source 778 such as an AC or DC source. Viacommunications paths 780, thetransmitter 775 andreceiver 777 communicate with asecond processor 782 having amemory 784. Theprocessor 782 communicates with avisual display 786 so that the practitioner can easily see the value of the measured body physiological parameter. In one embodiment, the display can display more than one physiological parameter at a time. In another, it can cycle between pages of displays. Analarm 788 is provided to aurally and/or visually indicate that one or more of the measured body physiological parameters has exceeded some acceptably defined range of values. In this manner, the patient and/or practitioner can react swiftly in taking corrective action. - An external connector(s) 790 is provided so that the transceiver can become more robust. In various embodiments, the external connector can connect by a direct wire or wireless link, such as by radio-frequency or infrared, to a printer, a general or special purpose computer, additional storage devices, faxes, internet, intranets, cell phone, personal data assistant, satellite, or other such computing or peripheral devices.
- It will be appreciated the exact embodiment of the
transceiver 770 can embody many forms. For example, in one embodiment it consists of patient strap-on module. In another, it is embodied as a wand to be passed over the patient's skin. In still another, it is coupled physically and electronically together with an infusion pump. - The transmitter and receiver pair of the
electronics package 760 and the transmitter and receiver pair of thetransceiver 770 may communicate via the use of an antenna associated with thePTC 736 orinfusion catheter 728. InFIGS. 9A and 9B , and 10A and 10B, anantenna 800 is shown withPTC 736. The catheter may have a length (l), and an inner and outer diameter (di and do). Theantenna 800 is disposed along a length thereof in a substantially straight manner (as shown), spirally wound manner, or may consist of a plurality of conductors, stranded or braided, to provide flexibility and ruggedness. Aterminal end 802 of theantenna 800 may be disposed in or adjacent the inner diameter (FIG. 9B ), adjacent the outer diameter (FIG. 10B ), or between the inner and outer diameters (FIG. 10A ). In still other embodiments, the antenna is disposed along only a portion of the length of the catheter and a plurality of antennas, instead of just the one shown, are arranged about the inner and outer diameters of the catheter. - The transmitter and receiver pairs may include appropriate modulators, demodulators, amplifiers, oscillators, etc., that are well known and necessary for transmitting and receiving signals, in order to accommodate
antenna 800. In some embodiments, it will be appreciated that the electronics package only includes a transmitter for communicating externally to the body and does not include a receiver and therefore cannot receive body external information. - With reference to
FIGS. 11A-11C , it will be appreciated that the VAP and PMA may, instead of being integrally formed, be combinable with one another before, during or after surgical implantation. In such instances, each of the VAP and the PMA have housings having mating, combinable features. For example, inFIG. 11A , the vascularaccess port housing 722 is slidingly engaged with thePMA housing 724 viamating slot 806 andtab 808 features arranged on anexternal surface FIG. 11B , the two housings are combinable in an interlocking fit configuration as aball 810 andsocket 812. It will be appreciated that the male/female parts may be switched and are not limited to the embodiments shown. InFIG. 11C , the two housings are combinable as acap 814 overbase 816 configuration. Still other embodiments include, but are not limited to, one-or-more snap-lock features, tongue-groove configurations, or other known or hereinafter invented arrangements. In still other embodiments, the two housings are compatible shapes but are not positively interlocking, such as with a donut shaped PMA surrounding a donut-hole shaped VAP. It should also be appreciated that in any of the foregoing embodiments, more than one PMA may be combined together with a VAP. Also, when made as combinable housings, flexibility is gained because the VAP and PMA can be made and shipped separate from one another and connected in the operating room upon implantation. - With reference to
FIG. 12 , another embodiment of a combined VAP and PMA is shown. In this embodiment, thecap 718 defines thefluid reservoir 754 and themating cap 718 andbase 720 pair contain both the VAP and the physiological monitoring device. Abezel 820 securesinfusion septum 734 wheninner ring 822 is inserted into thefluid reservoir 754. The inner ring is slightly smaller in diameter than the fluid reservoir. Aninner lip 824 on theouter ring 826 prevents the infusion septum from slipping out of the bezel. An outer lip 828 abuts a top 830 of thefluid reservoir 754 when the inner ring is inserted therein. An infusionseptum access port 742 provides needle access to the infusion septum during use. Aninfusion catheter 728 is fluidly interconnected to the fluid reservoir at aproximal end 730 for communicating a therapeutic agent from the needle (not shown) to a patient viadistal end 732 during use. - An
edge 746 of thecap 718 mates about awall periphery 748 of the base 720 to secure the cap and base together. Located between the cap and base, preferably as a hermetically sealed module, is theelectronics package 760,battery source 762,pressure sensor 832 andPTC 736. The electronics package and battery source are hemispherically arranged on asubstrate 764 to fit within theouter diameter portion 834 of thecap 718. Suture holes 726 are provided to secure the complete apparatus in a patient during use. An antenna, not shown, may also be included with such structure. - In
FIG. 13 , themating cap 718 andbase 720 sandwich anelectronics package 760,battery source 762 on asubstrate 764. As input to the physiological monitoring device, a pair ofECG electrodes 840 are mounted on abottom surface 841 of thebase 720. The ECG electrodes monitor an ECG waveform of the patient during use and are implanted in such a manner to achieve this. Electronic interconnections (not shown) provide communications between the electrodes and the electronics package. Thefluid reservoir 754 is defined by thecap 718 and is fluidly interconnected toinfusion catheter 728. APTC 736 is coupled to the cap and to the pressure sensor atproximal end 738. - Those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departures in form and detail may be made without departing from the scope and spirit of the present invention as described in the appended claims.
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/527,167 US20070049806A1 (en) | 2002-09-17 | 2006-09-25 | Vascular access port with physiological sensor |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/246,348 US7070591B2 (en) | 2002-09-17 | 2002-09-17 | Vascular access port with physiological sensor |
US11/402,158 US20060178617A1 (en) | 2002-09-17 | 2006-04-10 | Vascular access port with physiological sensor |
US11/527,167 US20070049806A1 (en) | 2002-09-17 | 2006-09-25 | Vascular access port with physiological sensor |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/402,158 Continuation US20060178617A1 (en) | 2002-09-17 | 2006-04-10 | Vascular access port with physiological sensor |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070049806A1 true US20070049806A1 (en) | 2007-03-01 |
Family
ID=31992310
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/246,348 Expired - Fee Related US7070591B2 (en) | 2002-09-17 | 2002-09-17 | Vascular access port with physiological sensor |
US11/402,158 Abandoned US20060178617A1 (en) | 2002-09-17 | 2006-04-10 | Vascular access port with physiological sensor |
US11/527,167 Abandoned US20070049806A1 (en) | 2002-09-17 | 2006-09-25 | Vascular access port with physiological sensor |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/246,348 Expired - Fee Related US7070591B2 (en) | 2002-09-17 | 2002-09-17 | Vascular access port with physiological sensor |
US11/402,158 Abandoned US20060178617A1 (en) | 2002-09-17 | 2006-04-10 | Vascular access port with physiological sensor |
Country Status (1)
Country | Link |
---|---|
US (3) | US7070591B2 (en) |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090227951A1 (en) * | 2005-04-27 | 2009-09-10 | C. R. Bard, Inc | Assemblies for identifying a power injectable access port |
US20100185711A1 (en) * | 2009-01-16 | 2010-07-22 | International Business Machines Corporation | Online monitoring of patient for routine checkups |
US20100305661A1 (en) * | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
EP2425770A1 (en) * | 2010-09-02 | 2012-03-07 | Juliana Castro Dourado Pinezi | Implantable device for real-time monitoring of glycemia and dosage |
US20120059236A1 (en) * | 2010-09-08 | 2012-03-08 | Juliana Castro Dourado Pinezi | Implantable device for real-time monitoring of glycemia and dosage |
EP2554213A1 (en) * | 2011-08-01 | 2013-02-06 | Centro de Estudios e Investigaciones Tecnicas (CEIT) | Intelligent subcutaneous venous access port and method for detecting biolayer |
US8382724B2 (en) | 2005-03-04 | 2013-02-26 | C. R. Bard, Inc. | Systems and methods for radiographically identifying an access port |
US8382723B2 (en) | 2005-03-04 | 2013-02-26 | C. R. Bard, Inc. | Access port identification systems and methods |
USD676955S1 (en) | 2010-12-30 | 2013-02-26 | C. R. Bard, Inc. | Implantable access port |
USD682416S1 (en) | 2010-12-30 | 2013-05-14 | C. R. Bard, Inc. | Implantable access port |
US8608713B2 (en) | 1998-12-07 | 2013-12-17 | C. R. Bard, Inc. | Septum feature for identification of an access port |
US8641676B2 (en) | 2005-04-27 | 2014-02-04 | C. R. Bard, Inc. | Infusion apparatuses and methods of use |
US8932271B2 (en) | 2008-11-13 | 2015-01-13 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
US8998860B2 (en) | 2005-03-04 | 2015-04-07 | C. R. Bard, Inc. | Systems and methods for identifying an access port |
US9079004B2 (en) | 2009-11-17 | 2015-07-14 | C. R. Bard, Inc. | Overmolded access port including anchoring and identification features |
US9265912B2 (en) | 2006-11-08 | 2016-02-23 | C. R. Bard, Inc. | Indicia informative of characteristics of insertable medical devices |
US9474888B2 (en) | 2005-03-04 | 2016-10-25 | C. R. Bard, Inc. | Implantable access port including a sandwiched radiopaque insert |
US9579496B2 (en) | 2007-11-07 | 2017-02-28 | C. R. Bard, Inc. | Radiopaque and septum-based indicators for a multi-lumen implantable port |
US9603993B2 (en) | 2005-03-04 | 2017-03-28 | C. R. Bard, Inc. | Access port identification systems and methods |
US9642986B2 (en) | 2006-11-08 | 2017-05-09 | C. R. Bard, Inc. | Resource information key for an insertable medical device |
US10307581B2 (en) | 2005-04-27 | 2019-06-04 | C. R. Bard, Inc. | Reinforced septum for an implantable medical device |
US10463845B2 (en) | 2013-01-23 | 2019-11-05 | C.R. Bard, Inc. | Low-profile access port |
USD870264S1 (en) | 2017-09-06 | 2019-12-17 | C. R. Bard, Inc. | Implantable apheresis port |
WO2020176670A1 (en) * | 2019-02-26 | 2020-09-03 | Percassist, Inc. | Apparatus, systems, and methods for percutaneous pneumatic cardiac assistance |
WO2020251786A1 (en) * | 2019-06-11 | 2020-12-17 | Bard Access Systems, Inc. | Intravenous system including pump, vascular access device and securement device and methods thereof |
US11420033B2 (en) | 2013-01-23 | 2022-08-23 | C. R. Bard, Inc. | Low-profile single and dual vascular access device |
US11464960B2 (en) | 2013-01-23 | 2022-10-11 | C. R. Bard, Inc. | Low-profile single and dual vascular access device |
US11490983B2 (en) | 2018-04-24 | 2022-11-08 | C. R. Bard, Inc. | Catheterization packages and methods thereof |
US11612715B2 (en) | 2018-06-20 | 2023-03-28 | C. R. Bard, Inc. | Urinary catheter-insertion kits with integrated instructions for use and methods thereof |
US11738171B2 (en) | 2013-10-16 | 2023-08-29 | C. R. Bard, Inc. | Catheter insertion tray with integrated instructions |
US11771880B2 (en) | 2019-07-17 | 2023-10-03 | Nxgenport, Llc | Implantable venous access port with remote physiological monitoring capabilities |
US11890443B2 (en) | 2008-11-13 | 2024-02-06 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
US11896778B2 (en) | 2017-03-31 | 2024-02-13 | C. R. Bard, Inc. | Catheter insertion-tray systems and methods thereof |
Families Citing this family (179)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7491232B2 (en) | 1998-09-18 | 2009-02-17 | Aptus Endosystems, Inc. | Catheter-based fastener implantation apparatus and methods with implantation force resolution |
US6997914B2 (en) * | 2001-04-02 | 2006-02-14 | Horizon Medical Products, Inc. | Implantable access port |
JP4498636B2 (en) | 2001-04-27 | 2010-07-07 | 日本サーモスタット株式会社 | Thermostat device |
US7197357B2 (en) * | 2001-07-17 | 2007-03-27 | Life Sync Corporation | Wireless ECG system |
US7933642B2 (en) * | 2001-07-17 | 2011-04-26 | Rud Istvan | Wireless ECG system |
EP1448117B1 (en) | 2001-11-28 | 2013-05-22 | Aptus Endosystems, Inc. | Endovascular aneurysm repair system |
US8231639B2 (en) | 2001-11-28 | 2012-07-31 | Aptus Endosystems, Inc. | Systems and methods for attaching a prosthesis within a body lumen or hollow organ |
US9320503B2 (en) | 2001-11-28 | 2016-04-26 | Medtronic Vascular, Inc. | Devices, system, and methods for guiding an operative tool into an interior body region |
US20070073389A1 (en) * | 2001-11-28 | 2007-03-29 | Aptus Endosystems, Inc. | Endovascular aneurysm devices, systems, and methods |
US20110087320A1 (en) * | 2001-11-28 | 2011-04-14 | Aptus Endosystems, Inc. | Devices, Systems, and Methods for Prosthesis Delivery and Implantation, Including a Prosthesis Assembly |
US20090112302A1 (en) * | 2001-11-28 | 2009-04-30 | Josh Stafford | Devices, systems, and methods for endovascular staple and/or prosthesis delivery and implantation |
US20050177180A1 (en) * | 2001-11-28 | 2005-08-11 | Aptus Endosystems, Inc. | Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US8858434B2 (en) | 2004-07-13 | 2014-10-14 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20040254513A1 (en) | 2002-04-10 | 2004-12-16 | Sherwin Shang | Conductive polymer materials and applications thereof including monitoring and providing effective therapy |
US10155082B2 (en) * | 2002-04-10 | 2018-12-18 | Baxter International Inc. | Enhanced signal detection for access disconnection systems |
US7052480B2 (en) | 2002-04-10 | 2006-05-30 | Baxter International Inc. | Access disconnection systems and methods |
US7022098B2 (en) | 2002-04-10 | 2006-04-04 | Baxter International Inc. | Access disconnection systems and methods |
EP2322798A1 (en) | 2002-10-09 | 2011-05-18 | Abbott Diabetes Care Inc. | Device and method for delivering medical fluids using a shape memory alloy |
US7727181B2 (en) * | 2002-10-09 | 2010-06-01 | Abbott Diabetes Care Inc. | Fluid delivery device with autocalibration |
US7993108B2 (en) | 2002-10-09 | 2011-08-09 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
US7679407B2 (en) | 2003-04-28 | 2010-03-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing peak detection circuitry for data communication systems |
US7429245B2 (en) | 2003-07-14 | 2008-09-30 | Welch Allyn, Inc. | Motion management in a fast blood pressure measurement device |
US9763609B2 (en) | 2003-07-25 | 2017-09-19 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US8626257B2 (en) * | 2003-08-01 | 2014-01-07 | Dexcom, Inc. | Analyte sensor |
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8886273B2 (en) | 2003-08-01 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
AU2004266574B2 (en) * | 2003-08-13 | 2010-11-04 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compressive device for percutaneous treatment of obesity |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US8615282B2 (en) | 2004-07-13 | 2013-12-24 | Dexcom, Inc. | Analyte sensor |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US8425416B2 (en) * | 2006-10-04 | 2013-04-23 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US8364230B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8532730B2 (en) * | 2006-10-04 | 2013-09-10 | Dexcom, Inc. | Analyte sensor |
US20080200788A1 (en) * | 2006-10-04 | 2008-08-21 | Dexcorn, Inc. | Analyte sensor |
US8425417B2 (en) | 2003-12-05 | 2013-04-23 | Dexcom, Inc. | Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device |
US8287453B2 (en) * | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
WO2006049725A2 (en) | 2004-03-23 | 2006-05-11 | Minimus Surgical Systems | Surgical systems and devices to enhance gastric restriction therapies |
US7255675B2 (en) * | 2004-03-23 | 2007-08-14 | Michael Gertner | Devices and methods to treat a patient |
US7946976B2 (en) * | 2004-03-23 | 2011-05-24 | Michael Gertner | Methods and devices for the surgical creation of satiety and biofeedback pathways |
US20070233170A1 (en) * | 2004-03-23 | 2007-10-04 | Michael Gertner | Extragastric Balloon |
US20060195139A1 (en) * | 2004-03-23 | 2006-08-31 | Michael Gertner | Extragastric devices and methods for gastroplasty |
US20060270922A1 (en) | 2004-07-13 | 2006-11-30 | Brauker James H | Analyte sensor |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
ATE520429T1 (en) * | 2004-11-16 | 2011-09-15 | Micromed Technology Inc | DISTANCE DATA MONITOR FOR A HEART PUMP SYSTEM |
US7775966B2 (en) * | 2005-02-24 | 2010-08-17 | Ethicon Endo-Surgery, Inc. | Non-invasive pressure measurement in a fluid adjustable restrictive device |
US7927270B2 (en) | 2005-02-24 | 2011-04-19 | Ethicon Endo-Surgery, Inc. | External mechanical pressure sensor for gastric band pressure measurements |
US7775215B2 (en) * | 2005-02-24 | 2010-08-17 | Ethicon Endo-Surgery, Inc. | System and method for determining implanted device positioning and obtaining pressure data |
US7699770B2 (en) * | 2005-02-24 | 2010-04-20 | Ethicon Endo-Surgery, Inc. | Device for non-invasive measurement of fluid pressure in an adjustable restriction device |
US7658196B2 (en) | 2005-02-24 | 2010-02-09 | Ethicon Endo-Surgery, Inc. | System and method for determining implanted device orientation |
US8016744B2 (en) | 2005-02-24 | 2011-09-13 | Ethicon Endo-Surgery, Inc. | External pressure-based gastric band adjustment system and method |
US8066629B2 (en) | 2005-02-24 | 2011-11-29 | Ethicon Endo-Surgery, Inc. | Apparatus for adjustment and sensing of gastric band pressure |
US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
CN101180093B (en) | 2005-03-21 | 2012-07-18 | 雅培糖尿病护理公司 | Method and system for providing integrated medication infusion and analyte monitoring system |
US20080161717A1 (en) * | 2005-05-10 | 2008-07-03 | Michael Eric Gertner | Obesity Treatment Systems |
US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
US7620437B2 (en) | 2005-06-03 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
US8251904B2 (en) | 2005-06-09 | 2012-08-28 | Roche Diagnostics Operations, Inc. | Device and method for insulin dosing |
US7756561B2 (en) | 2005-09-30 | 2010-07-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
CN101466316B (en) | 2005-10-20 | 2012-06-27 | 阿普特斯内系统公司 | Devices systems and methods for prosthesis delivery and implantation including the use of a fastener tool |
US7583190B2 (en) | 2005-10-31 | 2009-09-01 | Abbott Diabetes Care Inc. | Method and apparatus for providing data communication in data monitoring and management systems |
US7595723B2 (en) * | 2005-11-14 | 2009-09-29 | Edwards Lifesciences Corporation | Wireless communication protocol for a medical sensor system |
US20070112274A1 (en) * | 2005-11-14 | 2007-05-17 | Edwards Lifesciences Corporation | Wireless communication system for pressure monitoring |
US8344966B2 (en) | 2006-01-31 | 2013-01-01 | Abbott Diabetes Care Inc. | Method and system for providing a fault tolerant display unit in an electronic device |
US8920343B2 (en) | 2006-03-23 | 2014-12-30 | Michael Edward Sabatino | Apparatus for acquiring and processing of physiological auditory signals |
US8152710B2 (en) | 2006-04-06 | 2012-04-10 | Ethicon Endo-Surgery, Inc. | Physiological parameter analysis for an implantable restriction device and a data logger |
US8870742B2 (en) | 2006-04-06 | 2014-10-28 | Ethicon Endo-Surgery, Inc. | GUI for an implantable restriction device and a data logger |
US8187297B2 (en) | 2006-04-19 | 2012-05-29 | Vibsynt, Inc. | Devices and methods for treatment of obesity |
US7976554B2 (en) * | 2006-04-19 | 2011-07-12 | Vibrynt, Inc. | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US20110172767A1 (en) * | 2006-04-19 | 2011-07-14 | Pankaj Rathi | Minimally invasive, direct delivery methods for implanting obesity treatment devices |
US8556925B2 (en) * | 2007-10-11 | 2013-10-15 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8342183B2 (en) * | 2006-04-19 | 2013-01-01 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US20090275972A1 (en) * | 2006-04-19 | 2009-11-05 | Shuji Uemura | Minimally-invasive methods for implanting obesity treatment devices |
US20090281498A1 (en) * | 2006-04-19 | 2009-11-12 | Acosta Pablo G | Devices, system and methods for minimally invasive abdominal surgical procedures |
US20090281376A1 (en) * | 2006-04-19 | 2009-11-12 | Acosta Pablo G | Devices, system and methods for minimally invasive abdominal surgical procedures |
US8585733B2 (en) * | 2006-04-19 | 2013-11-19 | Vibrynt, Inc | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US20090272388A1 (en) * | 2006-04-19 | 2009-11-05 | Shuji Uemura | Minimally-invasive methods for implanting obesity treatment devices |
US20090287227A1 (en) * | 2006-04-19 | 2009-11-19 | Newell Matthew B | Minimally invasive ,methods for implanting obesity treatment devices |
US8398668B2 (en) | 2006-04-19 | 2013-03-19 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US20090281386A1 (en) * | 2006-04-19 | 2009-11-12 | Acosta Pablo G | Devices, system and methods for minimally invasive abdominal surgical procedures |
US8070768B2 (en) * | 2006-04-19 | 2011-12-06 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US20070260174A1 (en) * | 2006-05-05 | 2007-11-08 | Searete Llc | Detecting a failure to maintain a regimen |
US8275438B2 (en) | 2006-10-04 | 2012-09-25 | Dexcom, Inc. | Analyte sensor |
US8447376B2 (en) | 2006-10-04 | 2013-05-21 | Dexcom, Inc. | Analyte sensor |
US8478377B2 (en) | 2006-10-04 | 2013-07-02 | Dexcom, Inc. | Analyte sensor |
US8298142B2 (en) * | 2006-10-04 | 2012-10-30 | Dexcom, Inc. | Analyte sensor |
US8562528B2 (en) | 2006-10-04 | 2013-10-22 | Dexcom, Inc. | Analyte sensor |
US8449464B2 (en) | 2006-10-04 | 2013-05-28 | Dexcom, Inc. | Analyte sensor |
US8579853B2 (en) | 2006-10-31 | 2013-11-12 | Abbott Diabetes Care Inc. | Infusion devices and methods |
EP2066272A2 (en) * | 2006-12-28 | 2009-06-10 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8376978B2 (en) * | 2007-02-09 | 2013-02-19 | Baxter International Inc. | Optical access disconnection systems and methods |
US8152751B2 (en) | 2007-02-09 | 2012-04-10 | Baxter International Inc. | Acoustic access disconnection systems and methods |
US10463778B2 (en) | 2007-02-09 | 2019-11-05 | Baxter International Inc. | Blood treatment machine having electrical heartbeat analysis |
US20200037874A1 (en) | 2007-05-18 | 2020-02-06 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US8603050B2 (en) * | 2007-06-07 | 2013-12-10 | The Alfred E. Mann Foundation For Scientific Research | Implantable infusion devices including apparatus for confirming side port access |
US20080306444A1 (en) | 2007-06-08 | 2008-12-11 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
EP2164559B1 (en) | 2007-06-20 | 2017-10-25 | Medical Components, Inc. | Venous access port with molded and/or radiopaque indicia |
CA2693972C (en) | 2007-07-19 | 2019-01-15 | Medical Components, Inc. | Venous access port assembly with x-ray discernable indicia |
US9610432B2 (en) | 2007-07-19 | 2017-04-04 | Innovative Medical Devices, Llc | Venous access port assembly with X-ray discernable indicia |
AU2008299945A1 (en) * | 2007-09-07 | 2009-03-19 | Angiodynamics, Inc. | Implantable access port |
JP2010540197A (en) * | 2007-10-05 | 2010-12-24 | アンジオ ダイナミクス インコーポレイテッド | Dual reservoir embedded access port |
EP4159114B1 (en) | 2007-10-09 | 2024-04-10 | DexCom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7998089B2 (en) * | 2007-11-08 | 2011-08-16 | Radi Medical Systems Ab | Method of making a guide wire based assembly and reusing an energy source |
US8974398B2 (en) * | 2007-11-08 | 2015-03-10 | St. Jude Medical Coordination Center Bvba | Removable energy source for sensor guidewire |
US8187163B2 (en) | 2007-12-10 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Methods for implanting a gastric restriction device |
US8100870B2 (en) | 2007-12-14 | 2012-01-24 | Ethicon Endo-Surgery, Inc. | Adjustable height gastric restriction devices and methods |
US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8377079B2 (en) | 2007-12-27 | 2013-02-19 | Ethicon Endo-Surgery, Inc. | Constant force mechanisms for regulating restriction devices |
US8142452B2 (en) | 2007-12-27 | 2012-03-27 | Ethicon Endo-Surgery, Inc. | Controlling pressure in adjustable restriction devices |
US8591395B2 (en) | 2008-01-28 | 2013-11-26 | Ethicon Endo-Surgery, Inc. | Gastric restriction device data handling devices and methods |
US8192350B2 (en) | 2008-01-28 | 2012-06-05 | Ethicon Endo-Surgery, Inc. | Methods and devices for measuring impedance in a gastric restriction system |
US8337389B2 (en) | 2008-01-28 | 2012-12-25 | Ethicon Endo-Surgery, Inc. | Methods and devices for diagnosing performance of a gastric restriction system |
US8221439B2 (en) | 2008-02-07 | 2012-07-17 | Ethicon Endo-Surgery, Inc. | Powering implantable restriction systems using kinetic motion |
US7844342B2 (en) | 2008-02-07 | 2010-11-30 | Ethicon Endo-Surgery, Inc. | Powering implantable restriction systems using light |
US8114345B2 (en) | 2008-02-08 | 2012-02-14 | Ethicon Endo-Surgery, Inc. | System and method of sterilizing an implantable medical device |
US8591532B2 (en) | 2008-02-12 | 2013-11-26 | Ethicon Endo-Sugery, Inc. | Automatically adjusting band system |
US8057492B2 (en) | 2008-02-12 | 2011-11-15 | Ethicon Endo-Surgery, Inc. | Automatically adjusting band system with MEMS pump |
EP2252196A4 (en) | 2008-02-21 | 2013-05-15 | Dexcom Inc | Systems and methods for processing, transmitting and displaying sensor data |
US8034065B2 (en) | 2008-02-26 | 2011-10-11 | Ethicon Endo-Surgery, Inc. | Controlling pressure in adjustable restriction devices |
US8187162B2 (en) | 2008-03-06 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Reorientation port |
US8233995B2 (en) | 2008-03-06 | 2012-07-31 | Ethicon Endo-Surgery, Inc. | System and method of aligning an implantable antenna |
US20090275815A1 (en) * | 2008-03-21 | 2009-11-05 | Nova Biomedical Corporation | Temperature-compensated in-vivo sensor |
US8396528B2 (en) | 2008-03-25 | 2013-03-12 | Dexcom, Inc. | Analyte sensor |
AU2008354310B2 (en) | 2008-04-01 | 2014-02-20 | Gambro Lundia Ab | An apparatus and a method for monitoring a vascular access |
US8114043B2 (en) | 2008-07-25 | 2012-02-14 | Baxter International Inc. | Electromagnetic induction access disconnect sensor |
CA2740867C (en) | 2008-10-16 | 2018-06-12 | Aptus Endosystems, Inc. | Devices, systems, and methods for endovascular staple and/or prosthesis delivery and implantation |
US8126736B2 (en) | 2009-01-23 | 2012-02-28 | Warsaw Orthopedic, Inc. | Methods and systems for diagnosing, treating, or tracking spinal disorders |
US8685093B2 (en) | 2009-01-23 | 2014-04-01 | Warsaw Orthopedic, Inc. | Methods and systems for diagnosing, treating, or tracking spinal disorders |
US8560082B2 (en) | 2009-01-30 | 2013-10-15 | Abbott Diabetes Care Inc. | Computerized determination of insulin pump therapy parameters using real time and retrospective data processing |
WO2010129375A1 (en) | 2009-04-28 | 2010-11-11 | Abbott Diabetes Care Inc. | Closed loop blood glucose control algorithm analysis |
US8715244B2 (en) | 2009-07-07 | 2014-05-06 | C. R. Bard, Inc. | Extensible internal bolster for a medical device |
ES2888427T3 (en) | 2009-07-23 | 2022-01-04 | Abbott Diabetes Care Inc | Real-time management of data related to the physiological control of glucose levels |
US8945066B2 (en) | 2009-11-06 | 2015-02-03 | Crisi Medical Systems, Inc. | Medication injection site and data collection system |
US8808218B2 (en) * | 2010-01-29 | 2014-08-19 | Baxter International Inc. | Needle placement detection and security device and method |
US8444585B2 (en) * | 2010-01-29 | 2013-05-21 | Baxter International Inc. | Catheter needle retention and placement monitoring system and method |
US9101534B2 (en) | 2010-04-27 | 2015-08-11 | Crisi Medical Systems, Inc. | Medication and identification information transfer apparatus |
US9514131B1 (en) | 2010-05-30 | 2016-12-06 | Crisi Medical Systems, Inc. | Medication container encoding, verification, and identification |
US10492991B2 (en) | 2010-05-30 | 2019-12-03 | Crisi Medical Systems, Inc. | Medication container encoding, verification, and identification |
US8265556B2 (en) * | 2010-10-25 | 2012-09-11 | Waveworks, Inc. | Integrated mobile phone and medical implant monitoring system and method for using the same |
JP6141827B2 (en) | 2011-04-15 | 2017-06-07 | デックスコム・インコーポレーテッド | Method of operating a system for measuring an analyte and sensor system configured to implement the method |
EP2717765A4 (en) | 2011-06-08 | 2015-05-06 | Nader Najafi | Implantable wireless sensor systems |
US9078809B2 (en) | 2011-06-16 | 2015-07-14 | Crisi Medical Systems, Inc. | Medication dose preparation and transfer system |
US10293107B2 (en) | 2011-06-22 | 2019-05-21 | Crisi Medical Systems, Inc. | Selectively Controlling fluid flow through a fluid pathway |
US9744298B2 (en) | 2011-06-22 | 2017-08-29 | Crisi Medical Systems, Inc. | Selectively controlling fluid flow through a fluid pathway |
DE102011078711A1 (en) | 2011-07-06 | 2013-01-10 | Robert Bosch Gmbh | Implantable vascular access device for creating permanent access to blood vessels of patient and administrating drug, has hollow body that is provided with penetrating membrane, where hose is attached to hollow body with container system |
US8989873B2 (en) * | 2011-07-20 | 2015-03-24 | Medtronic, Inc. | Intravascular medical device with advancable electrode |
US9314362B2 (en) | 2012-01-08 | 2016-04-19 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
US8382775B1 (en) | 2012-01-08 | 2013-02-26 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
US9707339B2 (en) | 2012-03-28 | 2017-07-18 | Angiodynamics, Inc. | High flow rate dual reservoir port system |
US9713704B2 (en) | 2012-03-29 | 2017-07-25 | Bradley D. Chartrand | Port reservoir cleaning system and method |
US9205242B2 (en) | 2012-11-19 | 2015-12-08 | Angiodynamics, Inc. | Port septum with integral valve |
US10143830B2 (en) | 2013-03-13 | 2018-12-04 | Crisi Medical Systems, Inc. | Injection site information cap |
EP2859911A1 (en) * | 2013-10-11 | 2015-04-15 | qSTAR Medical SAS | Vascular access port devices with incorporated sensors |
US10166321B2 (en) | 2014-01-09 | 2019-01-01 | Angiodynamics, Inc. | High-flow port and infusion needle systems |
BR112017006984B1 (en) | 2014-10-10 | 2022-10-11 | Becton, Dickinson And Company | VOLTAGE CONTROL DEVICE AND LABELING SYSTEM |
AU2015330944B2 (en) | 2014-10-10 | 2018-04-05 | Becton, Dickinson And Company | Syringe labeling device |
EP3378421A1 (en) * | 2017-03-24 | 2018-09-26 | Koninklijke Philips N.V. | Endovascular device navigation |
EP3630230A4 (en) | 2017-05-21 | 2020-12-30 | Oncodisc, Inc. | Low profile implantable medication infusion port with electronic localization, physiologic monitoring, and data transfer |
WO2019060306A1 (en) * | 2017-09-19 | 2019-03-28 | Theranova, Llc | Methods and devices for fluid delivery and analyte sensing via an implantable port |
AU2018354120A1 (en) | 2017-10-24 | 2020-04-23 | Dexcom, Inc. | Pre-connected analyte sensors |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US20210038877A1 (en) * | 2018-03-12 | 2021-02-11 | Admetsys Corporation | Intravascular port based sensing and treatment system |
EP3586893A1 (en) | 2018-06-21 | 2020-01-01 | Medtronic, Inc. | Optimized intrathecal drug delivery |
EP3593833A1 (en) | 2018-07-13 | 2020-01-15 | Medtronic Inc. | Catheter for increased intrathecal drug dispersion |
EP3883461A1 (en) * | 2018-11-20 | 2021-09-29 | Oncodisc, Inc. | Vascular access devices for monitoring patient health |
US11096582B2 (en) * | 2018-11-20 | 2021-08-24 | Veris Health Inc. | Vascular access devices, systems, and methods for monitoring patient health |
TWI735137B (en) * | 2019-08-02 | 2021-08-01 | 華廣生技股份有限公司 | Physiological signal sensing device |
US11672476B2 (en) | 2019-09-17 | 2023-06-13 | Medtronic, Inc. | Intrathecal catheter with means to measure quality of drug dispersion |
US11344714B2 (en) | 2019-11-04 | 2022-05-31 | Medtronic, Inc. | Intrathecal catheter with features to reduce drug dispersion |
US20220023515A1 (en) * | 2020-07-22 | 2022-01-27 | Medtronic, Inc. | Thermal stimulation and subsequent cooling for fully implantable lvad controller |
WO2022076651A1 (en) * | 2020-10-08 | 2022-04-14 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Device for measurement of core body temperature and temperature monitoring methods |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5569186A (en) * | 1994-04-25 | 1996-10-29 | Minimed Inc. | Closed loop infusion pump system with removable glucose sensor |
US6453195B1 (en) * | 2001-03-19 | 2002-09-17 | Medtronic, Inc. | Closed loop drug delivery system and remote management thereof |
US6749587B2 (en) * | 2001-02-22 | 2004-06-15 | Insulet Corporation | Modular infusion device and method |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4796641A (en) * | 1987-07-06 | 1989-01-10 | Data Sciences, Inc. | Device and method for chronic in-vivo measurement of internal body pressure |
US4846191A (en) * | 1988-05-27 | 1989-07-11 | Data Sciences, Inc. | Device for chronic measurement of internal body pressure |
DE4319812C1 (en) * | 1993-06-15 | 1995-02-09 | Zurbruegg Heinz R | Implantable ultrasound probe for measuring the flow rate of blood in humans and animals |
US5387192A (en) * | 1994-01-24 | 1995-02-07 | Sims Deltec, Inc. | Hybrid portal and method |
US5487760A (en) * | 1994-03-08 | 1996-01-30 | Ats Medical, Inc. | Heart valve prosthesis incorporating electronic sensing, monitoring and/or pacing circuitry |
US5535752A (en) * | 1995-02-27 | 1996-07-16 | Medtronic, Inc. | Implantable capacitive absolute pressure and temperature monitor system |
US5995860A (en) * | 1995-07-06 | 1999-11-30 | Thomas Jefferson University | Implantable sensor and system for measurement and control of blood constituent levels |
US5931829A (en) * | 1997-01-21 | 1999-08-03 | Vasca, Inc. | Methods and systems for establishing vascular access |
US6527744B1 (en) * | 1997-08-27 | 2003-03-04 | Science Incorporated | Fluid delivery device with light activated energy source |
US6296615B1 (en) * | 1999-03-05 | 2001-10-02 | Data Sciences International, Inc. | Catheter with physiological sensor |
US6033366A (en) * | 1997-10-14 | 2000-03-07 | Data Sciences International, Inc. | Pressure measurement device |
US6064898A (en) | 1998-09-21 | 2000-05-16 | Essential Medical Devices | Non-invasive blood component analyzer |
US6285897B1 (en) * | 1999-04-07 | 2001-09-04 | Endonetics, Inc. | Remote physiological monitoring system |
-
2002
- 2002-09-17 US US10/246,348 patent/US7070591B2/en not_active Expired - Fee Related
-
2006
- 2006-04-10 US US11/402,158 patent/US20060178617A1/en not_active Abandoned
- 2006-09-25 US US11/527,167 patent/US20070049806A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5569186A (en) * | 1994-04-25 | 1996-10-29 | Minimed Inc. | Closed loop infusion pump system with removable glucose sensor |
US6749587B2 (en) * | 2001-02-22 | 2004-06-15 | Insulet Corporation | Modular infusion device and method |
US6453195B1 (en) * | 2001-03-19 | 2002-09-17 | Medtronic, Inc. | Closed loop drug delivery system and remote management thereof |
Cited By (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8608713B2 (en) | 1998-12-07 | 2013-12-17 | C. R. Bard, Inc. | Septum feature for identification of an access port |
US9682186B2 (en) | 2005-03-04 | 2017-06-20 | C. R. Bard, Inc. | Access port identification systems and methods |
US10857340B2 (en) | 2005-03-04 | 2020-12-08 | Bard Peripheral Vascular, Inc. | Systems and methods for radiographically identifying an access port |
US9603993B2 (en) | 2005-03-04 | 2017-03-28 | C. R. Bard, Inc. | Access port identification systems and methods |
US10905868B2 (en) | 2005-03-04 | 2021-02-02 | Bard Peripheral Vascular, Inc. | Systems and methods for radiographically identifying an access port |
US9603992B2 (en) | 2005-03-04 | 2017-03-28 | C. R. Bard, Inc. | Access port identification systems and methods |
US8382724B2 (en) | 2005-03-04 | 2013-02-26 | C. R. Bard, Inc. | Systems and methods for radiographically identifying an access port |
US8382723B2 (en) | 2005-03-04 | 2013-02-26 | C. R. Bard, Inc. | Access port identification systems and methods |
US10265512B2 (en) | 2005-03-04 | 2019-04-23 | Bard Peripheral Vascular, Inc. | Implantable access port including a sandwiched radiopaque insert |
US11077291B2 (en) | 2005-03-04 | 2021-08-03 | Bard Peripheral Vascular, Inc. | Implantable access port including a sandwiched radiopaque insert |
US10179230B2 (en) | 2005-03-04 | 2019-01-15 | Bard Peripheral Vascular, Inc. | Systems and methods for radiographically identifying an access port |
US8939947B2 (en) | 2005-03-04 | 2015-01-27 | C. R. Bard, Inc. | Systems and methods for radiographically identifying an access port |
US8585663B2 (en) | 2005-03-04 | 2013-11-19 | C. R. Bard, Inc. | Access port identification systems and methods |
US8603052B2 (en) | 2005-03-04 | 2013-12-10 | C. R. Bard, Inc. | Access port identification systems and methods |
US10238850B2 (en) | 2005-03-04 | 2019-03-26 | Bard Peripheral Vascular, Inc. | Systems and methods for radiographically identifying an access port |
US9474888B2 (en) | 2005-03-04 | 2016-10-25 | C. R. Bard, Inc. | Implantable access port including a sandwiched radiopaque insert |
US10675401B2 (en) | 2005-03-04 | 2020-06-09 | Bard Peripheral Vascular, Inc. | Access port identification systems and methods |
US8998860B2 (en) | 2005-03-04 | 2015-04-07 | C. R. Bard, Inc. | Systems and methods for identifying an access port |
US8545460B2 (en) | 2005-04-27 | 2013-10-01 | C. R. Bard, Inc. | Infusion apparatuses and related methods |
US10625065B2 (en) | 2005-04-27 | 2020-04-21 | Bard Peripheral Vascular, Inc. | Assemblies for identifying a power injectable access port |
US10183157B2 (en) | 2005-04-27 | 2019-01-22 | Bard Peripheral Vascular, Inc. | Assemblies for identifying a power injectable access port |
US20090227951A1 (en) * | 2005-04-27 | 2009-09-10 | C. R. Bard, Inc | Assemblies for identifying a power injectable access port |
US8641688B2 (en) | 2005-04-27 | 2014-02-04 | C. R. Bard, Inc. | Assemblies for identifying a power injectable access port |
US10661068B2 (en) | 2005-04-27 | 2020-05-26 | Bard Peripheral Vascular, Inc. | Assemblies for identifying a power injectable access port |
US10307581B2 (en) | 2005-04-27 | 2019-06-04 | C. R. Bard, Inc. | Reinforced septum for an implantable medical device |
US9937337B2 (en) | 2005-04-27 | 2018-04-10 | C. R. Bard, Inc. | Assemblies for identifying a power injectable access port |
US9421352B2 (en) | 2005-04-27 | 2016-08-23 | C. R. Bard, Inc. | Infusion apparatuses and methods of use |
US8641676B2 (en) | 2005-04-27 | 2014-02-04 | C. R. Bard, Inc. | Infusion apparatuses and methods of use |
US10052470B2 (en) | 2005-04-27 | 2018-08-21 | Bard Peripheral Vascular, Inc. | Assemblies for identifying a power injectable access port |
US8475417B2 (en) | 2005-04-27 | 2013-07-02 | C. R. Bard, Inc. | Assemblies for identifying a power injectable access port |
US10780257B2 (en) | 2005-04-27 | 2020-09-22 | Bard Peripheral Vascular, Inc. | Assemblies for identifying a power injectable access port |
US10016585B2 (en) | 2005-04-27 | 2018-07-10 | Bard Peripheral Vascular, Inc. | Assemblies for identifying a power injectable access port |
US9642986B2 (en) | 2006-11-08 | 2017-05-09 | C. R. Bard, Inc. | Resource information key for an insertable medical device |
US10556090B2 (en) | 2006-11-08 | 2020-02-11 | C. R. Bard, Inc. | Resource information key for an insertable medical device |
US10092725B2 (en) | 2006-11-08 | 2018-10-09 | C. R. Bard, Inc. | Resource information key for an insertable medical device |
US9265912B2 (en) | 2006-11-08 | 2016-02-23 | C. R. Bard, Inc. | Indicia informative of characteristics of insertable medical devices |
US10792485B2 (en) | 2007-11-07 | 2020-10-06 | C. R. Bard, Inc. | Radiopaque and septum-based indicators for a multi-lumen implantable port |
US9579496B2 (en) | 2007-11-07 | 2017-02-28 | C. R. Bard, Inc. | Radiopaque and septum-based indicators for a multi-lumen implantable port |
US10086186B2 (en) | 2007-11-07 | 2018-10-02 | C. R. Bard, Inc. | Radiopaque and septum-based indicators for a multi-lumen implantable port |
US11638810B2 (en) | 2007-11-07 | 2023-05-02 | C. R. Bard, Inc. | Radiopaque and septum-based indicators for a multi-lumen implantable port |
US8932271B2 (en) | 2008-11-13 | 2015-01-13 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
US10052471B2 (en) | 2008-11-13 | 2018-08-21 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
US10773066B2 (en) | 2008-11-13 | 2020-09-15 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
US11890443B2 (en) | 2008-11-13 | 2024-02-06 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
US9149187B2 (en) * | 2009-01-16 | 2015-10-06 | International Business Machines Corporation | Online monitoring of patient for routine checkups |
US20100185711A1 (en) * | 2009-01-16 | 2010-07-22 | International Business Machines Corporation | Online monitoring of patient for routine checkups |
US20100305661A1 (en) * | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US9184490B2 (en) * | 2009-05-29 | 2015-11-10 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US10369282B2 (en) * | 2009-05-29 | 2019-08-06 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11872370B2 (en) | 2009-05-29 | 2024-01-16 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US20160089493A1 (en) * | 2009-05-29 | 2016-03-31 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11369740B2 (en) | 2009-05-29 | 2022-06-28 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US10912935B2 (en) | 2009-11-17 | 2021-02-09 | Bard Peripheral Vascular, Inc. | Method for manufacturing a power-injectable access port |
US9079004B2 (en) | 2009-11-17 | 2015-07-14 | C. R. Bard, Inc. | Overmolded access port including anchoring and identification features |
US9248268B2 (en) | 2009-11-17 | 2016-02-02 | C. R. Bard, Inc. | Overmolded access port including anchoring and identification features |
US10155101B2 (en) | 2009-11-17 | 2018-12-18 | Bard Peripheral Vascular, Inc. | Overmolded access port including anchoring and identification features |
US11759615B2 (en) | 2009-11-17 | 2023-09-19 | Bard Peripheral Vascular, Inc. | Overmolded access port including anchoring and identification features |
US9717895B2 (en) | 2009-11-17 | 2017-08-01 | C. R. Bard, Inc. | Overmolded access port including anchoring and identification features |
EP2425770A1 (en) * | 2010-09-02 | 2012-03-07 | Juliana Castro Dourado Pinezi | Implantable device for real-time monitoring of glycemia and dosage |
US20120059236A1 (en) * | 2010-09-08 | 2012-03-08 | Juliana Castro Dourado Pinezi | Implantable device for real-time monitoring of glycemia and dosage |
USD682416S1 (en) | 2010-12-30 | 2013-05-14 | C. R. Bard, Inc. | Implantable access port |
USD676955S1 (en) | 2010-12-30 | 2013-02-26 | C. R. Bard, Inc. | Implantable access port |
EP2554213A1 (en) * | 2011-08-01 | 2013-02-06 | Centro de Estudios e Investigaciones Tecnicas (CEIT) | Intelligent subcutaneous venous access port and method for detecting biolayer |
US11420033B2 (en) | 2013-01-23 | 2022-08-23 | C. R. Bard, Inc. | Low-profile single and dual vascular access device |
US10463845B2 (en) | 2013-01-23 | 2019-11-05 | C.R. Bard, Inc. | Low-profile access port |
US11464960B2 (en) | 2013-01-23 | 2022-10-11 | C. R. Bard, Inc. | Low-profile single and dual vascular access device |
US11738171B2 (en) | 2013-10-16 | 2023-08-29 | C. R. Bard, Inc. | Catheter insertion tray with integrated instructions |
US11896778B2 (en) | 2017-03-31 | 2024-02-13 | C. R. Bard, Inc. | Catheter insertion-tray systems and methods thereof |
USD885557S1 (en) | 2017-09-06 | 2020-05-26 | C. R. Bard, Inc. | Implantable apheresis port |
USD870264S1 (en) | 2017-09-06 | 2019-12-17 | C. R. Bard, Inc. | Implantable apheresis port |
US11490983B2 (en) | 2018-04-24 | 2022-11-08 | C. R. Bard, Inc. | Catheterization packages and methods thereof |
US11937955B1 (en) | 2018-04-24 | 2024-03-26 | C. R. Bard, Inc. | Catheterization packages and methods thereof |
US11612715B2 (en) | 2018-06-20 | 2023-03-28 | C. R. Bard, Inc. | Urinary catheter-insertion kits with integrated instructions for use and methods thereof |
US11786696B1 (en) | 2018-06-20 | 2023-10-17 | C. R. Bard, Inc. | Urinary catheter-insertion kits |
US11918756B2 (en) | 2018-06-20 | 2024-03-05 | C. R. Bard, Inc. | Urinary catheter-insertion kits with integrated instructions for use and methods thereof |
US20210379357A1 (en) * | 2019-02-26 | 2021-12-09 | Percassist, Inc. | Apparatus, systems, and methods for percutaneous pneumatic cardiac assistance |
WO2020176670A1 (en) * | 2019-02-26 | 2020-09-03 | Percassist, Inc. | Apparatus, systems, and methods for percutaneous pneumatic cardiac assistance |
WO2020251786A1 (en) * | 2019-06-11 | 2020-12-17 | Bard Access Systems, Inc. | Intravenous system including pump, vascular access device and securement device and methods thereof |
US11771880B2 (en) | 2019-07-17 | 2023-10-03 | Nxgenport, Llc | Implantable venous access port with remote physiological monitoring capabilities |
Also Published As
Publication number | Publication date |
---|---|
US20060178617A1 (en) | 2006-08-10 |
US7070591B2 (en) | 2006-07-04 |
US20040054352A1 (en) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7070591B2 (en) | Vascular access port with physiological sensor | |
CA2305998C (en) | Catheter with pressure transducer next to the distal end | |
US8852099B2 (en) | Systems and methods for deriving relative physiologic measurements | |
US7736309B2 (en) | Implantable sensor method and system | |
JP4184795B2 (en) | Endocardial pressure measurement | |
US20060064134A1 (en) | Systems and methods for deriving relative physiologic measurements | |
EP1740267A2 (en) | Implantable medical devices and related methods | |
US20200288989A1 (en) | Measuring cardiovascular pressure based on patient state | |
US9241638B2 (en) | System and method for implanting a physiologic sensor assembly | |
US20220322952A1 (en) | Performing one or more pulse transit time measurements based on an electrogram signal and a photoplethysmography signal | |
CN110087534B (en) | Hydrostatic offset adjustment for measured cardiovascular pressure values | |
CN116096288A (en) | Dynamic bioimpedance range adjustment for medical devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: TRANSOMA MEDICAL, INC., MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:DATA SCIENCES INTERNATIONAL;REEL/FRAME:021760/0591 Effective date: 20030423 Owner name: DATA SCIENCES INTERNATIONAL, MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ADAMS, H. CLARK;BROCKWAY, BRIAN P.;MILLS, PERRY A.;REEL/FRAME:021760/0412;SIGNING DATES FROM 20020909 TO 20020910 |
|
AS | Assignment |
Owner name: PARTNERS FOR GROWTH II, L.P., CALIFORNIA Free format text: SECURITY AGREEMENT;ASSIGNOR:TRANSOMA MEDICAL, INC.;REEL/FRAME:022678/0382 Effective date: 20090512 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: DATA SCIENCES INTERNATIONAL, INC.,MINNESOTA Free format text: FORECLOSURE;ASSIGNOR:TRANSOMA MEDICAL, INC.;REEL/FRAME:024120/0696 Effective date: 20091228 Owner name: DATA SCIENCES INTERNATIONAL, INC., MINNESOTA Free format text: FORECLOSURE;ASSIGNOR:TRANSOMA MEDICAL, INC.;REEL/FRAME:024120/0696 Effective date: 20091228 |
|
AS | Assignment |
Owner name: TRANSOMA MEDICAL, INC.,MINNESOTA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:PARTNERS FOR GROWTH II, L.P.;REEL/FRAME:024588/0100 Effective date: 20100510 Owner name: TRANSOMA MEDICAL, INC., MINNESOTA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:PARTNERS FOR GROWTH II, L.P.;REEL/FRAME:024588/0100 Effective date: 20100510 |